<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Paracetamol versus placebo for knee and hip osteoarthritis - Leopoldino, AO - 2019 | Cochrane Library</title> <meta content="Paracetamol versus placebo for knee and hip osteoarthritis - Leopoldino, AO - 2019 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013273/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Paracetamol versus placebo for knee and hip osteoarthritis - Leopoldino, AO - 2019 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013273/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD013273" name="dc.identifier" scheme="DOI"/> <meta content="Paracetamol versus placebo for knee and hip osteoarthritis" name="citation_title"/> <meta content="Amanda O Leopoldino" name="citation_author"/> <meta content="Sydney Medical School, The University of Sydney" name="citation_author_institution"/> <meta content="Gustavo C Machado" name="citation_author"/> <meta content="Sydney Medical School, The University of Sydney" name="citation_author_institution"/> <meta content="Paulo H Ferreira" name="citation_author"/> <meta content="The University of Sydney" name="citation_author_institution"/> <meta content="Marina B Pinheiro" name="citation_author"/> <meta content="The University of Sydney" name="citation_author_institution"/> <meta content="Richard Day" name="citation_author"/> <meta content="St. Vincent's Hospital" name="citation_author_institution"/> <meta content="Andrew J McLachlan" name="citation_author"/> <meta content="University of Sydney" name="citation_author_institution"/> <meta content="David J Hunter" name="citation_author"/> <meta content="The University of Sydney" name="citation_author_institution"/> <meta content="Manuela L Ferreira" name="citation_author"/> <meta content="Sydney Medical School, The University of Sydney" name="citation_author_institution"/> <meta content="manuela.ferreira@sydney.edu.au" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="2" name="citation_issue"/> <meta content="10.1002/14651858.CD013273" name="citation_doi"/> <meta content="2019" name="citation_date"/> <meta content="2019/02/25" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013273/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013273/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013273/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Acetaminophen [administration &amp; dosage, adverse effects, *therapeutic use]; Analgesics, Non‐Narcotic [administration &amp; dosage, adverse effects, *therapeutic use]; Arthralgia [*drug therapy, etiology]; Liver [drug effects]; Osteoarthritis, Hip [*drug therapy]; Osteoarthritis, Knee [*drug therapy]; Pain Measurement; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013273&amp;doi=10.1002/14651858.CD013273&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013273&amp;doi=10.1002/14651858.CD013273&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013273&amp;doi=10.1002/14651858.CD013273&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013273&amp;doi=10.1002/14651858.CD013273&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013273&amp;doi=10.1002/14651858.CD013273&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013273&amp;doi=10.1002/14651858.CD013273&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013273&amp;doi=10.1002/14651858.CD013273&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013273&amp;doi=10.1002/14651858.CD013273&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013273&amp;doi=10.1002/14651858.CD013273&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013273&amp;doi=10.1002/14651858.CD013273&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013273&amp;doi=10.1002/14651858.CD013273&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013273&amp;doi=10.1002/14651858.CD013273&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013273&amp;doi=10.1002/14651858.CD013273&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013273&amp;doi=10.1002/14651858.CD013273&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013273&amp;doi=10.1002/14651858.CD013273&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013273&amp;doi=10.1002/14651858.CD013273&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013273&amp;doi=10.1002/14651858.CD013273&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013273&amp;doi=10.1002/14651858.CD013273&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013273&amp;doi=10.1002/14651858.CD013273&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013273&amp;doi=10.1002/14651858.CD013273&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013273&amp;doi=10.1002/14651858.CD013273&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013273&amp;doi=10.1002/14651858.CD013273&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013273&amp;doi=10.1002/14651858.CD013273&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="PMzGcYGP";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD013273\x26doi\x3d10\x2e1002\x2f14651858\x2eCD013273\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013273\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013273\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","zh_HANS","ru","ms","fr","pl","hr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD013273",title:"Paracetamol versus placebo for knee and hip osteoarthritis",firstPublishedDate:"Feb 25, 2019 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Musculoskeletal Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=PMzGcYGP&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013273&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013273';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD013273/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD013273/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013273%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD013273/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013273/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD013273/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013273/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD013273" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD013273/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD013273" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD013273/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD013273/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>18218 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD013273" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013273/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013273/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013273/full#CD013273-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013273/full#CD013273-sec-0093"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013273/full#CD013273-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013273/full#CD013273-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013273/full#CD013273-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013273/full#CD013273-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013273/full#CD013273-sec-0060"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013273/full#CD013273-sec-0087"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD013273/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013273/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013273/appendices#CD013273-sec-0098"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013273/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013273/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/table_n/CD013273StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/table_n/CD013273StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013273/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013273/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013273/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013273/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013273/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD013273/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD013273/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Paracetamol versus placebo for knee and hip osteoarthritis</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013273/information#CD013273-cr-0002">Amanda O Leopoldino</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013273/information#CD013273-cr-0003">Gustavo C Machado</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013273/information#CD013273-cr-0004">Paulo H Ferreira</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013273/information#CD013273-cr-0005">Marina B Pinheiro</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013273/information#CD013273-cr-0006">Richard Day</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013273/information#CD013273-cr-0007">Andrew J McLachlan</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013273/information#CD013273-cr-0008">David J Hunter</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013273/information#CD013273-cr-0009"><i class="icon corresponding-author fa fa-envelope"></i>Manuela L Ferreira</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD013273/information/en#CD013273-sec-0110">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 25 February 2019 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD013273/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD013273">https://doi.org/10.1002/14651858.CD013273</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD013273-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013273-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013273-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013273-abs-0014">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013273-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013273-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD013273-abs-0001" lang="en"> <section id="CD013273-sec-0001"> <h3 class="title" id="CD013273-sec-0001">Background</h3> <p>Paracetamol (acetaminophen) is vastly recommended as the first‐line analgesic for osteoarthritis of the hip or knee. However, there has been controversy about this recommendation given recent studies have revealed small effects of paracetamol when compared with placebo. Nonetheless, past studies have not systematically reviewed and appraised the literature to investigate the effects of this drug on specific osteoarthritis sites, that is, hip or knee, or on the dose used. </p> </section> <section id="CD013273-sec-0002"> <h3 class="title" id="CD013273-sec-0002">Objectives</h3> <p>To assess the benefits and harms of paracetamol compared with placebo in the treatment of osteoarthritis of the hip or knee. </p> </section> <section id="CD013273-sec-0003"> <h3 class="title" id="CD013273-sec-0003">Search methods</h3> <p>We searched the Cochrane Central Register of Controlled Trials, MEDLINE, Embase, AMED, CINAHL, Web of Science, LILACS, and International Pharmaceutical Abstracts to 3 October 2017, and ClinicalTrials.gov and the World Health Organization International Clinical Trials Registry Platform (ICTRP) portal on 20 October 2017. </p> </section> <section id="CD013273-sec-0004"> <h3 class="title" id="CD013273-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials comparing paracetamol with placebo in adults with osteoarthritis of the hip or knee. Major outcomes were pain, function, quality of life, adverse events and withdrawals due to adverse events, serious adverse events, and abnormal liver function tests. </p> </section> <section id="CD013273-sec-0005"> <h3 class="title" id="CD013273-sec-0005">Data collection and analysis</h3> <p>Two review authors used standard Cochrane methods to collect data, and assess risk of bias and quality of the evidence. For pooling purposes, we converted pain and physical function (Western Ontario and McMaster Universities Osteoarthritis Index function) scores to a common 0 (no pain or disability) to 100 (worst possible pain or disability) scale. </p> </section> <section id="CD013273-sec-0006"> <h3 class="title" id="CD013273-sec-0006">Main results</h3> <p>We identified 10 randomised placebo‐controlled trials involving 3541 participants with hip or knee osteoarthritis. The paracetamol dose varied from 1.95 g/day to 4 g/day, and the majority of trials followed participants for three months only. Most trials did not clearly report randomisation and concealment methods and were at unclear risk of selection bias. Trials were at low risk of performance, detection, and reporting bias. </p> <p>At 3 weeks' to 3 months' follow‐up, there was high‐quality evidence that paracetamol provided no clinically important improvements in pain and physical function. Mean reduction in pain was 23 points (0 to 100 scale, lower scores indicated less pain) with placebo and 3.23 points better (5.43 better to 1.02 better) with paracetamol, an absolute reduction of 3% (1% better to 5% better, minimal clinical important difference 9%) and relative reduction of 5% (2% better to 8% better) (seven trials, 2355 participants). Physical function improved by 12 points on a 0 to 100 scale (lower scores indicated better function) with placebo and was 2.9 points better (0.95 better to 4.89 better) with paracetamol, an absolute improvement of 3% (1% better to 5% better, minimal clinical important difference 10%) and relative improvement of 5% (2% better to 9% better) (7 trials, 2354 participants). </p> <p>High‐quality evidence from eight trials indicated that the incidence of adverse events was similar between groups: 515/1586 (325 per 1000) in the placebo group versus 537/1666 (328 per 1000, range 299 to 360) in the paracetamol group (risk ratio (RR) 1.01, 95% confidence interval (CI) 0.92 to 1.11). There was less certainty (moderate‐quality evidence) around the risk of serious adverse events, withdrawals due to adverse events, and the rate of abnormal liver function tests, due to wide CIs or small event rates, indicating imprecision. Seventeen of 1480 (11 per 1000) people treated with placebo and 28/1729 (16 per 1000, range 8 to 29) people treated with paracetamol experienced serious adverse events (RR 1.36, 95% CI 0.73 to 2.53; 6 trials). The incidence of withdrawals due to adverse events was 65/1000 participants in with placebo and 77/1000 (range 59 to 100) participants with paracetamol (RR 1.19, 95% CI 0.91 to 1.55; 7 trials). Abnormal liver function occurred in 18/1000 participants treated with placebo and 70/1000 participants treated with paracetamol (RR 3.79, 95% CI 1.94 to 7.39), but the clinical importance of this effect was uncertain. None of the trials reported quality of life. </p> <p>Subgroup analyses indicated that the effects of paracetamol on pain and function did not differ according to the dose of paracetamol (3.0 g/day or less versus 3.9 g/day or greater). </p> </section> <section id="CD013273-sec-0007"> <h3 class="title" id="CD013273-sec-0007">Authors' conclusions</h3> <p>Based on high‐quality evidence this review confirms that paracetamol provides only minimal improvements in pain and function for people with hip or knee osteoarthritis, with no increased risk of adverse events overall. Subgroup analysis indicates that the effects on pain and function do not differ according to the dose of paracetamol. Due to the small number of events, we are less certain if paracetamol use increases the risk of serious adverse events, withdrawals due to adverse events, and rate of abnormal liver function tests. </p> <p>Current clinical guidelines consistently recommend paracetamol as the first‐line analgesic medication for hip or knee osteoarthritis, given its low absolute frequency of substantive harm. However, our results call for reconsideration of these recommendations. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD013273-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013273-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD013273-abs-0006">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD013273-abs-0012">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013273-abs-0015">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013273-abs-0010">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD013273-abs-0013">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ms#CD013273-abs-0009">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD013273-abs-0011">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD013273-abs-0008">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013273-abs-0007">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD013273-abs-0005" lang="en"> <h3>Paracetamol for treating people with hip or knee osteoarthritis</h3> <p><b>Background</b> </p> <p>Osteoarthritis of the hip or knee is a progressive disabling disease affecting many people worldwide. Although paracetamol is widely used as a treatment option for this condition, recent studies have called into question how effective this pain relief medication is. </p> <p><b>Search date</b> </p> <p>This review includes all trials published up to 3 October 2017.</p> <p><b>Study characteristics</b> </p> <p>We included randomised clinical trials (where people are randomly put into one of two treatment groups) looking at the effects of paracetamol for people with hip or knee pain due to osteoarthritis against a placebo (a 'sugar tablet' that contains nothing that could act as a medicine). We found 10 trials with 3541 participants. On average, participants in the study were aged between 55 and 70 years, and most presented with knee osteoarthritis. The treatment dose ranged from 1.95 g/day to 4 g/day of paracetamol and participants were followed up between one and 12 weeks in all but one study, which followed people up for 24 weeks. Six trials were funded by companies that produced paracetamol. </p> <p><b>Key results</b> </p> <p>Compared with placebo tablets, paracetamol resulted in little benefit at 12 weeks.</p> <p>Pain (lower scores mean less pain) </p> <p>Improved by 3% (1% better to 5% better), or 3.2 points (1 better to 5.4 better) on a 0‐ to 100‐point scale. </p> <p>• People who took paracetamol reported that their pain improved by 26 points.</p> <p>• People who took placebo reported that their pain improved by 23 points.</p> <p>Physical function (lower scores mean better function) </p> <p>Improved by 3% (1% better to 5% better), or 2.9 points (1.0 better to 4.9 better) on a 0‐ to 100‐point scale. </p> <p>• People who took paracetamol reported that their function improved by 15 points.</p> <p>• People who had placebo reported that their function improved by 12 points.</p> <p>Side effects (up to 12 to 24 weeks) </p> <p>No more people had side effects with paracetamol (3% less to 3% more), or 0 more people out of 100. </p> <p>• 33 out of 100 people reported a side effect with paracetamol.</p> <p>• 33 out of 100 people reported a side effect with placebo.</p> <p>Serious side effects (up to 12 to 24 weeks) </p> <p>1% more people had serious side effects with paracetamol (0% less to 1% more), or one more person out of 100. </p> <p>• Two out of 100 people reported a serious side effect with paracetamol.</p> <p>• One out of 100 people reported a serious side effect with placebo.</p> <p>Withdrawals due to adverse events (up to 12 to 24 weeks) </p> <p>1% more people withdrew from treatment with paracetamol (1% less to 3% more), or one more person out of 100. </p> <p>• Eight out of 100 people withdrew from paracetamol treatment.</p> <p>• Seven out of 100 people withdrew from placebo treatment.</p> <p>Abnormal liver function tests (up to 12 to 24 weeks): </p> <p>5% more people had abnormal liver function tests (meaning there was some inflammation or damage to the liver) with paracetamol (1% more to 10% more), or five more people out of 100. </p> <p>• Seven out of 100 people had an abnormal liver function test with paracetamol.</p> <p>• Two out of 100 people had an abnormal liver function test with placebo.</p> <p><b>Quality of the evidence</b> </p> <p>High‐quality evidence indicated that paracetamol provided only minimal improvements in pain and function for people with hip or knee osteoarthritis, with no increased risk of adverse events overall. None of the studies measured quality of life. Due to the small number of events, we were less certain if paracetamol use increased the risk of serious side effects, increased withdrawals due to side effects, and changed the rate of abnormal liver function tests. However, although there may be more abnormal liver function tests with paracetamol, the clinical implications are unknown. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD013273-sec-0093" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD013273-sec-0093"></div> <h3 class="title" id="CD013273-sec-0094">Implications for practice</h3> <section id="CD013273-sec-0094"> <p>Despite guidelines for the treatment of non‐traumatic knee complaints recommending paracetamol as the first‐choice analgesic in treating pain due to osteoarthritis (<a href="./references#CD013273-bbs2-0048" title="JordanKM , ArdenNK , DohertyM , BannwarthB , BijlsmaJW , DieppeP , et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Annals of the Rheumatic Diseases2003;62(12):1145‐55. ">Jordan 2003</a>; <a href="./references#CD013273-bbs2-0068" title="ZhangW , MoskowitzRW , NukiG , AbramsonS , AltmanRD , ArdenN , et al. OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis and Cartilage2007;15(19):981‐1000. ">Zhang 2007</a>), this updated review confirms previous findings that paracetamol provides minimal, probably clinically unimportant benefits in the immediate and short term for people with hip or knee osteoarthritis. Moreover, paracetamol does not provide statistically significant or clinically important effects for people with knee osteoarthritis only. </p> </section> <h3 class="title" id="CD013273-sec-0095">Implications for research</h3> <section id="CD013273-sec-0095"> <p>The use of drugs as an intervention has been previously associated with improvements on pain and physical function in people with osteoarthritis (<a href="./references#CD013273-bbs2-0027" title="BarthelHR , PenistonJH , ClarkMB , GoldMS , AltmanRD . Correlation of pain relief with physical function in hand osteoarthritis: randomized controlled trial post hoc analysis. Arthritis Research &amp; Therapy2010;12(1):R7. ">Barthel 2010</a>; <a href="./references#CD013273-bbs2-0059" title="ScheinJR , KosinskiMR , Janagap‐BensonC , GajriaK , LinP , FreedmanJD . Functionality and health‐status benefits associated with reduction of osteoarthritis pain. Current Medical Research and Opinion2008;24:1255‐65. ">Schein 2008</a>). However, this Cochrane systematic review including only randomised placebo‐controlled trials investigating the benefits and harms of paracetamol compared with placebo for hip and knee osteoarthritis revealed that paracetamol alone does not offer clinically important benefits for this population. These results were consistent irrespective of the dose of paracetamol or pain location. Future research should focus on developing and implementing models of care that are focused on evidence‐based non‐pharmacological approaches for the care of knee and hip osteoarthritis. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD013273-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD013273-sec-0029"></div> <div class="table" id="CD013273-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Paracetamol versus placebo for hip or knee osteoarthritis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Paracetamol versus placebo for hip or knee osteoarthritis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Population:</b> people with hip or knee osteoarthritis </p> <p><b>Settings:</b> various rehabilitation, orthopaedic, or rheumatology clinics </p> <p><b>Intervention:</b> paracetamol </p> <p><b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>What happens</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Paracetamol</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean change in pain</b> </p> <p>(0–100 scale)</p> <p>Short term (3–12 weeks), where 0 = no pain</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in pain score in the placebo group was –23<sup>a</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in pain score in the paracetamol group was <b>3.2 points lower</b> (1.0 lower to 5.4 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD –3.23</b> </p> <p>(–5.43 to –1.02)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2355 (7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>High</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinically unimportant improvement; absolute change 3% better (5% better to 1% better); relative change 5% better (2% better to 8% better)<sup>b</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Physical function</b> </p> <p>(WOMAC function 0–100)</p> <p>3–12 weeks, 0 = better function</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in physical function score in the placebo group was –12<sup>a</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean physical function score in the paracetamol group was <b>2.9 points lower</b> (4.9 lower to 1.0 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD –2.92</b> </p> <p>(–4.89 to –0.95)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2354 (7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>High</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinically unimportant improvement; absolute change 3% better (5% better to 1% better); relative change 5% better (2% better to 9% better)<sup>b</sup>. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> <p>Not measured</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Withdrawals due to adverse events</b> </p> <p>24 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>65 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>77 per 1000</b> </p> <p>(59 to 100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.19</b> (0.91 to 1.55) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3023 (7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The difference was not statistically or clinically significant; absolute change 1% more withdrew with paracetamol (1% less to 3% more); relative change 19% more (9% less to 55% more). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total adverse events: number experiencing</b> </p> <p>24 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>325 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>328 per 1000</b><br/> (299 to 360) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.01</b> </p> <p>(0.92 to 1.11)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3252 (8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>High</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The difference was not statistically or clinically significant; absolute change: no more events with paracetamol (3% less to 3% more); relative change 1% more (8% less to 11% more). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Liver toxicity: number experiencing abnormal liver function tests</b> </p> <p>24 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>18 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>70 per 1000</b><br/> (36 to 136) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 3.79</b> </p> <p>(1.94<b>to</b> 7.39) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1237 (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The clinical impact of the higher risk of abnormal liver function tests was unclear; absolute change 5% more abnormal tests with paracetamol (1% more to 10% more); relative change 279% more (94% more to 639% more). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Serious adverse events: number experiencing</b> </p> <p>24 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>11 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>16 per 1000</b><br/> (8 to 29) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.36</b> </p> <p>(0.73 to 2.53)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3209 (6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute change: no more events with paracetamol (up to 1% more); relative change 36% more (27% less to 153% more). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> was the median control group risk across studies. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>MD:</b> mean difference;<b>RR:</b> risk ratio; <b>WOMAC:</b> Western Ontario and McMaster Universities Osteoarthritis Index. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Based on score in placebo group at 3 months' follow‐up as reported in <a href="./references#CD013273-bbs2-0006" title="Miceli‐RichardC , LeBarsM , SchmidelyN , DougadosM . Paracetamol in osteoarthritis of the knee. Annals of the Rheumatic Diseases2004;63(8):923‐30. ">Miceli‐Richard 2004</a>. </p> <p><sup>b</sup>Relative changes calculated as absolute change (mean difference) divided by mean at baseline in the placebo group from <a href="./references#CD013273-bbs2-0006" title="Miceli‐RichardC , LeBarsM , SchmidelyN , DougadosM . Paracetamol in osteoarthritis of the knee. Annals of the Rheumatic Diseases2004;63(8):923‐30. ">Miceli‐Richard 2004</a> (mean values were: 69.0 (standard deviation 17) on 0‐ to 100‐point visual analogue pain scale; and 54.0 (standard deviation 15) on 0‐ to 100‐point WOMAC function subscale). </p> <p><sup>c</sup>Downgraded by one level due to imprecision (small number of events, or the 95% confidence intervals do not exclude a clinically important change). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD013273-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD013273-sec-0030"></div> <p>Osteoarthritis of the hip or knee is the 11th highest contributor to global disability, when disability is measured by years lived with disability (<a href="./references#CD013273-bbs2-0063" title="VosT , FlaxmanAD , NaghaviM , LozanoR , MichaudC , EzzatiM , et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet2012;380:2163‐96. ">Vos 2012</a>), and its global prevalence is estimated at 4% (<a href="./references#CD013273-bbs2-0033" title="CrossM , SmithE , HoyD , NolteS , AckermanI , FransenM , et al. The global burden of hip and knee osteoarthritis: estimates from the Global Burden of Disease 2010 study. Annals of the Rheumatic Diseases2014;73:1323‐30. ">Cross 2014</a>; <a href="./references#CD013273-bbs2-0047" title="HoyD , MarchL , BrooksP , BlythF , WoolfA , BainC , et al. The global burden of low back pain: estimates from the Global Burden of Disease 2010 study. Annals of the Rheumatic Diseases2014;73:968‐74. ">Hoy 2014</a>). In this context, it is important to manage osteoarthritis in an effective and efficient way (<a href="./references#CD013273-bbs2-0026" title="BartenDJ , DorsmanSA , DekkerJ , VeenhofC , BakkerDH . Treatment of hip/knee osteoarthritis in Dutch general practice and physical therapy practice: an observational study. BMC Family Practice2015;16(1):75. ">Barten 2015</a>), and the control of pain symptoms is an important component of treatment (<a href="./references#CD013273-bbs2-0009" title="PriorMJ , HarrisonDD , FrustaciME . A randomized, double‐blind, placebo‐controlled 12 week trial of acetaminophen extended release for the treatment of signs and symptoms of osteoarthritis. Current Medical Research &amp; Opinion2014;30(11):2377‐87. ">Prior 2014</a>). The use of paracetamol (acetaminophen) is consistently recommended as the first‐line analgesic for this condition (<a href="./references#CD013273-bbs2-0046" title="HochbergMC , AltmanRD , AprilKT , BenkhaltiM , GuyattG , McGowanJ , et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care and Research2012;64:465‐74. ">Hochberg 2012</a>; <a href="./references#CD013273-bbs2-0067" title="ZhangW , DohertyM , ArdenN , BannwarthB , BijlsmaJ , GuntherKP , et al. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Annals of the Rheumatic Diseases2005;64:669‐81. ">Zhang 2005</a>). However, there has been controversy about using paracetamol in international clinical guidelines, mainly because previous studies have reported small effects for the medication compared with placebo (<a href="./references#CD013273-bbs2-0061" title="TowheedTE , MaxwellL , JuddMG , CattonM , HochbergMC , WellsG . Acetaminophen for osteoarthritis. Cochrane Database of Systematic Reviews2006, Issue 1. [DOI: 10.1002/14651858.CD004257.pub2] ">Towheed 2006</a>; <a href="./references#CD013273-bbs2-0066" title="ZhangW , JonesA , DohertyM . Does paracetamol (acetaminophen) reduce the pain of osteoarthritis? A meta‐analysis of randomised controlled trials. Annals of the Rheumatic Diseases2004;63(8):901‐7. ">Zhang 2004</a>; <a href="./references#CD013273-bbs2-0069" title="ZhangWG , NukiRW , MoskowitzS , AbramsonRD , AltmanNK , ArdenS , et al. OARSI recommendations for the management of hip and knee osteoarthritis: part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis and Cartilage2010;18(4):476‐99. ">Zhang 2010</a>). The perceived safety profile of paracetamol over other analgesics such as non‐steroidal anti‐inflammatory drugs (NSAIDs), has led to the increase of its use, resulting in paracetamol being among the most common non‐prescription medications used for osteoarthritis. However, there is evidence linking paracetamol with increased risk of gastrointestinal, cardiovascular, and kidney diseases, and mortality (<a href="./references#CD013273-bbs2-0058" title="RobertsE , Delgado NunesV , BucknerS , LatchemS , ConstantiM , MillerP , et al. Paracetamol: not as safe as we thought? A systematic literature review of observational studies. Annals of the Rheumatic Diseases2016;75(3):552‐9. ">Roberts 2016</a>). A Cochrane Review of placebo‐controlled trials investigating the benefits of paracetamol for hip or knee osteoarthritis could provide credible information for clinical decision‐making based on the highest standard of evidence. This review is an update of a meta‐analysis on paracetamol for spinal pain or osteoarthritis (<a href="./references#CD013273-bbs2-0052" title="MachadoGC , MaherCG , FerreiraPH , PinheiroMB , LinCW , DayRO , et al. Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta‐analysis of randomised placebo controlled trials. BMJ2015;350:1225. ">Machado 2015</a>). </p> <section id="CD013273-sec-0031"> <h3 class="title" id="CD013273-sec-0031">Description of the condition</h3> <p>Osteoarthritis is a complex and progressive joint disease characterised by focal cartilage loss, accompanied by subchondral bone changes and involvement of all joint tissues as deterioration of tendons and ligaments, and various degrees of inflammation of the synovium resulting from biomechanical and systemic effects (<a href="./references#CD013273-bbs2-0046" title="HochbergMC , AltmanRD , AprilKT , BenkhaltiM , GuyattG , McGowanJ , et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care and Research2012;64:465‐74. ">Hochberg 2012</a>; <a href="./references#CD013273-bbs2-0069" title="ZhangWG , NukiRW , MoskowitzS , AbramsonRD , AltmanNK , ArdenS , et al. OARSI recommendations for the management of hip and knee osteoarthritis: part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis and Cartilage2010;18(4):476‐99. ">Zhang 2010</a>). This prevalent disease is associated with significant pain, stiffness, functional impairment, and reduced quality of life (<a href="./references#CD013273-bbs2-0031" title="BuckwalterJA , MartinJA . Osteoarthritis. Advanced Drug Delivery Reviews2006;20(58):150‐67. ">Buckwalter 2006</a>; <a href="./references#CD013273-bbs2-0065" title="WoolfAD , PflegerB . Burden of major musculoskeletal conditions. Bulletin of the World Health Organization2003;81(9):646‐56. ">Woolf 2003</a>), resulting in a large societal and economic burden (<a href="./references#CD013273-bbs2-0026" title="BartenDJ , DorsmanSA , DekkerJ , VeenhofC , BakkerDH . Treatment of hip/knee osteoarthritis in Dutch general practice and physical therapy practice: an observational study. BMC Family Practice2015;16(1):75. ">Barten 2015</a>). </p> </section> <section id="CD013273-sec-0032"> <h3 class="title" id="CD013273-sec-0032">Description of the intervention</h3> <p>Paracetamol is an antipyretic and analgesic medication that is not thought to have significant anti‐inflammatory properties. Although its mechanism of inducing analgesia is not yet completely understood, the drug is thought to work in part by decreasing production of prostaglandins through inhibitory effects involving cyclo‐oxygenase‐2 (COX‐2) (<a href="./references#CD013273-bbs2-0032" title="CroffordLJ . Rational use of analgesic and antiinflammatory drugs. New England Journal of Medicine2001;20(345):1844‐6. ">Crofford 2001</a>; <a href="./references#CD013273-bbs2-0038" title="GrahamGG , GrahamRI , DayRO . Comparative analgesia, cardiovascular and renal effects of celecoxib, rofecoxib and acetaminophen (paracetamol). Current Pharmaceutical Design2002;8(12):1063‐75. ">Graham 2002</a>; <a href="./references#CD013273-bbs2-0040" title="GrahamGG , DaviesMJ , DayRO , MohamudallyA , ScottKF . The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology2013;21(3):201‐32. ">Graham 2013</a>). Clinical practice guidelines for osteoarthritis management recommend paracetamol as the first choice when pain medication for osteoarthritis is needed, because of its safer profile compared with NSAIDs, particularly in people who are at risk of gastrointestinal ulcer (<a href="./references#CD013273-bbs2-0067" title="ZhangW , DohertyM , ArdenN , BannwarthB , BijlsmaJ , GuntherKP , et al. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Annals of the Rheumatic Diseases2005;64:669‐81. ">Zhang 2005</a>; <a href="./references#CD013273-bbs2-0068" title="ZhangW , MoskowitzRW , NukiG , AbramsonS , AltmanRD , ArdenN , et al. OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis and Cartilage2007;15(19):981‐1000. ">Zhang 2007</a>). If paracetamol does not provide sufficient pain relief, then NSAIDs or other physical treatments may be considered (<a href="./references#CD013273-bbs2-0025" title="BartelsE M , JuhlC B , ChristensenR , HagenK B , Danneskiold‐SamsoeB , DagfinrudH , et al. Aquatic exercise for the treatment of knee and hip osteoarthritis. Cochrane Database of Systematic Reviews2016, Issue 3. [DOI: 10.1002/14651858.CD005523.pub3] ">Bartels 2016</a>; <a href="./references#CD013273-bbs2-0034" title="DerryS , ConaghanP , DaSilvaJA , WiffenPJ , MooreRA . Topical NSAIDs for chronic musculoskeletal pain in adults. Cochrane Database of Systematic Reviews 2016, Issue 4. Art. No.: CD007400. DOI: 10.1002/14651858.CD007400.pub3. ">Derry 2016</a>; <a href="./references#CD013273-bbs2-0051" title="JüniP , HariR , RutjesAW , FischerR , SillettaMG , ReichenbachS , et al. Intra‐articular corticosteroid for knee osteoarthritis. Cochrane Database of Systematic Reviews2015, Issue 10. [DOI: 10.1002/14651858.CD005328.pub3] ">Jüni 2015</a>; <a href="./references#CD013273-bbs2-0054" title="PuljakL , MarinA , VrdoljakD , MarkoticF , UtrobicicA , TugwellP . Celecoxib for osteoarthritis. Cochrane Database of Systematic Reviews 2017, Issue 5. Art. No.: CD009865. DOI: 10.1002/14651858.CD009865.pub2. ">Puljak 2017</a>; <a href="./references#CD013273-bbs2-0055" title="RegnauxJP , Lefevre‐ColauMM , TrinquartL , NguyenC , BoutronI , BrosseauL , et al. High‐intensity versus low‐intensity physical activity or exercise in people with hip or knee osteoarthritis. Cochrane Database of Systematic Reviews2015, Issue 10. [DOI: 10.1002/14651858.CD010203.pub2] ">Regnaux 2015</a>; <a href="./references#CD013273-bbs2-0060" title='SminkAJ , van denEndeCH , Vliet VlielandTP , SwierstraBA , KortlandJH , BijlsmaJW , et al. "Beating osteoARThritis": development of a stepped care strategy to optimize utilization and timing of non‐surgical treatment modalities for patients with hip or knee osteoarthritis. Clinical Rheumatology2011;30(12):1623‐9. '>Smink 2011</a>). </p> </section> <section id="CD013273-sec-0033"> <h3 class="title" id="CD013273-sec-0033">How the intervention might work</h3> <p>The details of the mechanism of action of paracetamol are now becoming clearer after its use for more than a century (<a href="./references#CD013273-bbs2-0040" title="GrahamGG , DaviesMJ , DayRO , MohamudallyA , ScottKF . The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology2013;21(3):201‐32. ">Graham 2013</a>). It is agreed that paracetamol inhibits the production of prostaglandins, which are mediators of fever, pain, and inflammation, by blocking the cyclo‐oxygenase pathways (<a href="./references#CD013273-bbs2-0040" title="GrahamGG , DaviesMJ , DayRO , MohamudallyA , ScottKF . The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology2013;21(3):201‐32. ">Graham 2013</a>). Paracetamol may have more central than peripheral analgesic effects and has similar but weaker anti‐inflammatory actions than NSAIDs, such as ibuprofen (<a href="./references#CD013273-bbs2-0039" title="GrahamGG , ScottKF . Mechanisms of action of paracetamol and related analgesics. Inflammopharmacology2003;11(4):401‐13. ">Graham 2003</a>; <a href="./references#CD013273-bbs2-0040" title="GrahamGG , DaviesMJ , DayRO , MohamudallyA , ScottKF . The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology2013;21(3):201‐32. ">Graham 2013</a>). Indeed, its pharmacological profile is of a weak selective COX‐2 inhibitor (<a href="./references#CD013273-bbs2-0045" title="HinzB , ChereminaO , BruneK . Acetaminophen (paracetamol) is a selective cyclooxygenase‐2 inhibitor in man. FASEB Journal2008;22(2):383‐90. ">Hinz 2008</a>). One feature of paracetamol is its effectiveness in low levels of inflammation such as seen with tooth extraction. However, in contrast to selective COX‐2 inhibitors including celecoxib, paracetamol does not decrease intense inflammatory states such as rheumatoid arthritis or gout. COX‐1 and COX‐2 are bifunctional enzymes with cyclo‐oxygenase and peroxidase functions. Paracetamol is an inhibitor of the peroxidase function of COX‐1 and COX‐2 enzymes. From this process, it is effective in reducing prostaglandin synthesis when there are low levels of arachidonic acid, the precursor of prostaglandins. The analgesic effect of paracetamol is dependent upon several neurotransmitter systems in the central nervous system, including serotonin, opiate, and endogenous cannabinoid systems. In experimental studies, inhibitors of these systems block the analgesic effects of paracetamol (<a href="./references#CD013273-bbs2-0040" title="GrahamGG , DaviesMJ , DayRO , MohamudallyA , ScottKF . The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology2013;21(3):201‐32. ">Graham 2013</a>). </p> </section> <section id="CD013273-sec-0034"> <h3 class="title" id="CD013273-sec-0034">Why it is important to do this review</h3> <p>Pain is the most common symptom of osteoarthritis, and as pain levels rise, people experience a reduced range of motion and impaired physical function. The pain and functional limitations substantially reduce the quality of life of people with osteoarthritis. Paracetamol is a widely used analgesic for hip or knee osteoarthritis but the evidence on its benefits and harms remains controversial (<a href="./references#CD013273-bbs2-0061" title="TowheedTE , MaxwellL , JuddMG , CattonM , HochbergMC , WellsG . Acetaminophen for osteoarthritis. Cochrane Database of Systematic Reviews2006, Issue 1. [DOI: 10.1002/14651858.CD004257.pub2] ">Towheed 2006</a>; <a href="./references#CD013273-bbs2-0066" title="ZhangW , JonesA , DohertyM . Does paracetamol (acetaminophen) reduce the pain of osteoarthritis? A meta‐analysis of randomised controlled trials. Annals of the Rheumatic Diseases2004;63(8):901‐7. ">Zhang 2004</a>; <a href="./references#CD013273-bbs2-0069" title="ZhangWG , NukiRW , MoskowitzS , AbramsonRD , AltmanNK , ArdenS , et al. OARSI recommendations for the management of hip and knee osteoarthritis: part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis and Cartilage2010;18(4):476‐99. ">Zhang 2010</a>). The current review was conducted according to the guidelines recommended by the Cochrane Musculoskeletal Group Editorial Board (<a href="./references#CD013273-bbs2-0037" title="GhogomuEA , MaxwellLJ , BuchbinderR , RaderT , Pardo PardoJ , JohnstonRV , et al. Updated method guidelines for Cochrane musculoskeletal group systematic reviews and metaanalyses. Journal of Rheumatology2014;41(2):194‐205. ">Ghogomu 2014</a>), and is an update of the <a href="./references#CD013273-bbs2-0052" title="MachadoGC , MaherCG , FerreiraPH , PinheiroMB , LinCW , DayRO , et al. Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta‐analysis of randomised placebo controlled trials. BMJ2015;350:1225. ">Machado 2015</a> review published in <i>BMJ</i> on 31 March 2015. This Cochrane Review has focused on data for hip and knee osteoarthritis and has included subgroup analysis on the dosage of paracetamol (i.e. 3.0 g/day or less or 3.9 g/day or more). Our updated search focusing on osteoarthritis trials identified 726 additional records; however, none of these records were eligible to be included in the review according to our inclusion criteria. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD013273-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD013273-sec-0035"></div> <p>To assess the benefits and harms of paracetamol (acetaminophen) compared with placebo in the treatment of osteoarthritis of the hip or knee. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD013273-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD013273-sec-0036"></div> <section id="CD013273-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD013273-sec-0038"> <h4 class="title">Types of studies</h4> <p>We included only published (full reports in a peer‐reviewed journal) randomised controlled trials comparing the benefits and harms of paracetamol with placebo for osteoarthritis of the hip or knee. Trials with quasi‐random allocation procedures were not included to avoid biased estimates of treatment effects. There were no restrictions for language or publication date. </p> </section> <section id="CD013273-sec-0039"> <h4 class="title">Types of participants</h4> <p>We included only people with osteoarthritis of the hip or knee (intensity and duration of symptoms were not restricted). Both clinical and imaging‐based diagnoses of osteoarthritis were included in the review. People of any level of healthcare could be included: primary, secondary, or tertiary. We excluded trials evaluating analgesia in the immediate postoperative period, although studies in which participants had previous hip, or knee surgery were eligible, studies with mixed populations of participants with rheumatoid arthritis and osteoarthritis were also excluded, unless separate data were provided for osteoarthritis. </p> </section> <section id="CD013273-sec-0040"> <h4 class="title">Types of interventions</h4> <p>Randomised controlled trials comparing the benefits of any dose regimen or administration mode of paracetamol versus placebo for hip or knee osteoarthritis. We have not included any study assessing the benefit and harm of the combination of paracetamol with any other type of medication. </p> </section> <section id="CD013273-sec-0041"> <h4 class="title">Types of outcome measures</h4> <section id="CD013273-sec-0042"> <h5 class="title">Major outcomes</h5> <p>The <b>major outcomes</b> were pain intensity, physical function, and quality of life ‐ as currently recommended for osteoarthritis trials (<a href="./references#CD013273-bbs2-0024" title="AltmanR , BrandtK , HochbergM , MoskowitzR , BellamyN , BlochDA , et al. Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop. Osteoarthritis Cartilage1996;4(4):217‐43. ">Altman 1996</a>; <a href="./references#CD013273-bbs2-0053" title="PhamT , Van derHeijdeD , AltmanRD , AndersonJJ , BellamyN , HochbergM , et al. OMERACT‐OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis and Cartilage2004;12(5):389‐99. ">Pham 2004</a>), adverse events, serious adverse events, withdrawals due to adverse events, and liver toxicity. If data for more than one pain scale were provided in a trial, we referred to a previously described hierarchy of pain‐related outcomes (<a href="./references#CD013273-bbs2-0049" title="JuhlC , LundH , RoosEM , ZhangW , ChristensenR . A hierarchy of patient‐reported outcomes for meta‐analysis of knee osteoarthritis trials: empirical evidence from a survey of high impact journals. Arthritis2012;2012:1‐17. ">Juhl 2012</a>; <a href="./references#CD013273-bbs2-0050" title="JüniP , ReichenbachS , DieppeP . Osteoarthritis: rational approach to treating the individual. Best Practice and Research2006;20(4):720‐40. ">Jüni 2006</a>; <a href="./references#CD013273-bbs2-0056" title="ReichenbachS , SterchiR , SchererM , TrelleS , BurgiE , BurgiU , et al. Meta‐analysis: chondroitin for osteoarthritis of the knee or hip. Annals of Internal Medicine2007;146(8):580‐90. ">Reichenbach 2007</a>), and extracted data on the pain scale that was highest on this list: </p> <p> <ul id="CD013273-list-0001"> <li> <p>Pain intensity</p> <ul id="CD013273-list-0002"> <li> <p>pain overall;</p> </li> <li> <p>pain on walking;</p> </li> <li> <p>Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain subscale;</p> </li> <li> <p>pain on activities other than walking;</p> </li> <li> <p>WOMAC global scale;</p> </li> <li> <p>Lequesne Osteoarthritis Index global score;</p> </li> <li> <p>other algofunctional scale;</p> </li> <li> <p>patient’s global assessment;</p> </li> <li> <p>physician's global assessment;</p> </li> <li> <p>other outcome;</p> </li> <li> <p>no continuous outcome reported.</p> </li> </ul> </li> </ul> </p> <p>If a trial provided data on more than one physical function impairment scale, we extracted data according to the following hierarchy: </p> <p> <ul id="CD013273-list-0003"> <li> <p>Physical function</p> <ul id="CD013273-list-0004"> <li> <p>global disability score;</p> </li> <li> <p>walking disability;</p> </li> <li> <p>WOMAC disability subscore;</p> </li> <li> <p>composite disability scores other than WOMAC;</p> </li> <li> <p>disability other than walking;</p> </li> <li> <p>Lequesne Osteoarthritis Index global score;</p> </li> <li> <p>other algofunctional scale.</p> </li> </ul> </li> </ul> <ul id="CD013273-list-0005"> <li> <p>Quality of life.</p> </li> <li> <p>Withdrawals due to adverse events.</p> </li> <li> <p>Total adverse events.</p> </li> <li> <p>Liver toxicity (positive alterations in liver function tests).</p> </li> <li> <p>Serious adverse events.</p> </li> </ul> </p> </section> <section id="CD013273-sec-0043"> <h5 class="title">Minor outcomes</h5> <p> <ul id="CD013273-list-0006"> <li> <p>Walking disability.</p> </li> <li> <p>Rescue medication (rate of participants using rescue medication).</p> </li> <li> <p>Patient adherence (rate of participants who adhered to at least 85% of prescribed number of tablets per day). </p> </li> <li> <p>Long‐term toxicity (rate of participants reporting long‐term toxicity).</p> </li> </ul> </p> <p>Radiographic joint structure changes (e.g. joint space width) were not included in this review, as it is unlikely paracetamol will have an effect on this outcome, thus we substituted liver toxicity as a major outcome. </p> </section> </section> </section> <section id="CD013273-sec-0044"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD013273-sec-0045"> <h4 class="title">Electronic searches</h4> <p>We updated the search (3 October 2017) on the following electronic databases, without restrictions on language: </p> <p> <ul id="CD013273-list-0007"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL): via OvidSP, 1991 to October 2017; </p> </li> <li> <p>MEDLINE: via OvidSP, 1946 to September Week 3 2017;</p> </li> <li> <p>Embase: via OvidSP, 1974 to September 2017;</p> </li> <li> <p>Allied and Complementary Medicine Database (AMED): via OvidSP, 1985 to September 2017;</p> </li> <li> <p>Cumulative Index to Nursing and Allied Health Literature (CINAHL): via EBSCO, 1982 to September 2017; </p> </li> <li> <p>Web of Science: via Thomson Reuters, 1900 to September 2017;</p> </li> <li> <p>Latin American and Caribbean Literature in Health Sciences (LILACS): via BIREME, 1986 to September 2017; </p> </li> <li> <p>International Pharmaceutical Abstracts (IPA): via OvidSP, 1970 to September 2017.</p> </li> </ul> </p> <p>We used a combination of relevant keywords to construct the search strategy including paracetamol, acetaminophen, osteoarthritis, osteoarthrosis, placebo, randomised, and controlled trial. Two review authors (GCM and MBP) conducted the first screening of potentially relevant records based on titles and abstract, and three review authors (GCM, MBP, and AAO for the update) independently performed the final selection of included trials based on full‐text evaluation. We performed citation tracking on included studies and relevant systematic reviews, and searched relevant websites and clinical trials registries for unpublished studies. We resolved disagreements by consensus between the three review authors. The search strategy for each database is presented in the following appendices: <a href="./appendices#CD013273-sec-0099">Appendix 1</a> (CENTRAL), <a href="./appendices#CD013273-sec-0100">Appendix 2</a> (MEDLINE), <a href="./appendices#CD013273-sec-0101">Appendix 3</a> (Embase), <a href="./appendices#CD013273-sec-0102">Appendix 4</a> (AMED), <a href="./appendices#CD013273-sec-0103">Appendix 5</a> (CINAHL), <a href="./appendices#CD013273-sec-0104">Appendix 6</a> (Web of Sciences), <a href="./appendices#CD013273-sec-0105">Appendix 7</a> (LILACS), and <a href="./appendices#CD013273-sec-0106">Appendix 8</a> (IPA). </p> </section> <section id="CD013273-sec-0046"> <h4 class="title">Searching other resources</h4> <p>The review authors had previously contacted the pharmaceutical manufacturers for details of unpublished and ongoing trials. We searched and identified the relevant trials or reviews in reference lists. We also searched clinical trial registries (<a href="https://clinicaltrials.gov/" target="_blank">ClinicalTrials.gov</a>) and the World Health Organization (WHO) International Clinical Trials Registry Platform (<a href="http://apps.who.int/trialsearch/" target="_blank">ICTRP</a>) on 20 October 2017, and asked personal contacts about ongoing and unpublished studies. There were no language or publication restrictions. See search strategy for unpublished and ongoing trials in <a href="./appendices#CD013273-sec-0107">Appendix 9</a>. </p> </section> </section> <section id="CD013273-sec-0047"> <h3 class="title" id="CD013273-sec-0047">Data collection and analysis</h3> <section id="CD013273-sec-0048"> <h4 class="title">Selection of studies</h4> <p>Three review authors (GCM, MBP, and AAO) independently screened the titles and abstracts of studies identified by the updated searches using a standardised data extraction form to eliminate those that clearly did not satisfy the inclusion criteria. We obtained full reports for the remaining studies to determine inclusion in the review. A fourth review author (MLF) resolved any disagreements. If multiple reports described the same trial, we considered all. In case of multiple reports of the same study, these were collated, so that each study, rather than each report, was the unit of interest in the review. </p> </section> <section id="CD013273-sec-0049"> <h4 class="title">Data extraction and management</h4> <p>Three review authors (GCM, MBP, and AAO) independently extracted trial information using a standardised data collection form. Review authors were not blinded to the authors' names and institutions, journal of publication, or study results at any stage of the review. We resolved disagreements through discussion. One review author (AAO) entered data suitable for meta‐analysis into Review Manager 5 (<a href="./references#CD013273-bbs2-0057" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">Review Manager 2012</a>), and another review author (GCM) double checked entries. We extracted the following data: </p> <p> <ul id="CD013273-list-0008"> <li> <p>bibliometric data: authors, affiliations, language, and year of publication;</p> </li> <li> <p>characteristics of included trials: trial design, sample size, details of participants, inclusion and exclusion criteria, characteristics of the experimental intervention, type of control used, dosage, frequency, duration of treatment interventions, duration of follow‐up, and primary and secondary outcomes; </p> </li> <li> <p>characteristics of included participants: age, sex, type of diagnosis for hip and knee osteoarthritis, types of joints affected (knee, hip, or both), and duration of symptoms; </p> </li> <li> <p>statistical data: means, standard deviations (SD), and sample sizes for major outcomes. We extracted mean estimates in the following hierarchical order: change scores, and final values. </p> </li> </ul> </p> <p>For our minor outcomes, we extracted the number of cases and the total sample size. The safety outcomes extracted from included trials were the number of participants reporting any adverse effect, number of participants reporting any serious adverse effect (as defined by each study), number of participants who withdrew from the study because of adverse effects, and number of participants with abnormal results on liver function tests (hepatic enzyme activity 1.5 times the upper limit of the reference range or greater). </p> </section> <section id="CD013273-sec-0050"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (GCM and MBP) independently assessed 'Risk of bias' for each study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD013273-bbs2-0044" title="HigginsJP , AltmanDG , SterneJA . Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). We assessed each included study within the following 'Risk of bias' domains: adequacy of sequence generation, allocation concealment and blinding, how incomplete outcome data (dropouts) were addressed, evidence of selective outcome reporting, and whether trials were funded by companies that produced paracetamol. We resolved disagreements by consensus. We used Review Manager 5 to generate figures and summaries (<a href="./references#CD013273-bbs2-0057" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">Review Manager 2012</a>). </p> </section> <section id="CD013273-sec-0051"> <h4 class="title">Measures of treatment effect</h4> <p>We used risk ratio (RR) and 95% confidence intervals (CI) for dichotomous data based on the number of events in the control and intervention groups of each study. For continuous data, we calculated mean differences (MD) and 95% CI between paracetamol and placebo groups. Pain and physical function (WOMAC function) scores were converted to a common 0 (no pain or disability) to 100 (worst possible pain or disability) scale before meta‐analysis. We considered a minimal clinically important difference (MCID) of 9 points on a 100‐point scale for pain and physical function outcomes based upon the practice in the osteoarthritis field (<a href="./references#CD013273-bbs2-0064" title="WandelS , JüniP , TendalB , NüeschE , VilligerPM , WeltonNJ , et al. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta‐analysis. BMJ2010;341(16):4675. ">Wandel 2010</a>). </p> <p>In the Comments column of the 'Summary of findings' table, we reported the absolute percent difference, the relative percent change from baseline, and the number needed to treat for an additional beneficial outcome (NNTB), or number needed to treat for an additional harmful outcome (NNTH) (NNTB and NNTH were provided only when the outcome showed a clinically important difference between treatment groups). </p> <p>For dichotomous outcomes, such as adverse events, we calculated the NNTB or NNTH from the control group event rate and the relative risk using the Visual Rx NNT calculator (<a href="http://archie.cochrane.org/sections/documents/view?version=z1404080656100343590228158459076%26format=REVMAN#REF-Cates-2008" target="_blank">Cates 2008</a>). We calculated the NNTB for continuous measures using the Wells calculator (available at the CMSG Editorial office, <a href="http://musculoskeletal.cochrane.org/" target="_blank">musculoskeletal.cochrane.org/</a>). We used the MCID to interpret results, and for input into the Wells calculator. We assumed an MCID of 9 points in a 10‐point scale for pain (<a href="./references#CD013273-bbs2-0064" title="WandelS , JüniP , TendalB , NüeschE , VilligerPM , WeltonNJ , et al. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta‐analysis. BMJ2010;341(16):4675. ">Wandel 2010</a>); and 10 points on a 100‐point scale for function or disability. </p> <p>For dichotomous outcomes, we calculated the absolute risk difference using the Risk Difference statistic in Review Manager 5 and expressed the result as a percentage. For continuous outcomes, we calculated the absolute benefit as the improvement in the intervention group minus the improvement in the control group (MD), in the original units, and expressed it as a percentage. </p> <p>We calculated the relative percent change for dichotomous data as the RR – 1 and expressed it as a percentage. For continuous outcomes, we calculated the relative difference as the absolute benefit divided by the baseline mean of the control group, expressed as a percentage. </p> </section> <section id="CD013273-sec-0052"> <h4 class="title">Unit of analysis issues</h4> <p>Seven included studies were traditional randomised parallel‐group trials and three were crossover trials (<a href="./references#CD013273-bbs2-0007" title="PincusT , KochG , LeiH , MangalB , MangalB , SokkaT , MoskowitzR , et al. Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis. Annals of the Rheumatic Diseases2004;63(8):931‐9. ">Pincus 2004a</a>; <a href="./references#CD013273-bbs2-0008" title="PincusT , KochG , LeiH , MangalB , MangalB , SokkaT , MoskowitzR , et al. Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis. Annals of the Rheumatic Diseases2004;63(8):931‐9. ">Pincus 2004b</a>; <a href="./references#CD013273-bbs2-0002" title="AmadioP , DoyleM . Evaluation of acetaminophen in the management of osteoarthritis of the knee. Current Therapeutic Research – Clinical and Experimental1983;34(1):59‐66. ">Amadio 1983</a>). The unit of analysis was between‐person for all trials. We stratified all outcomes into four time points of assessment for the primary analyses: immediate term (two weeks or less), short term (more than two weeks but three months or less), intermediate term (more than three months but 12 months or less), and long term (more than 12 months). When studies reported multiple time points within each category, we used the time point closest to one week for immediate term, eight weeks for short term, six months for intermediate term, and 12 months for long term (although no studies reported long‐term outcomes and only one reported intermediate‐term outcomes). For studies reporting on multiple intervention groups (e.g. groups of different dosages) and included in the same pooled analysis, we halved the sample size of the placebo group to avoid unit of analysis issues. </p> </section> <section id="CD013273-sec-0053"> <h4 class="title">Dealing with missing data</h4> <p>We contacted the authors of the studies to obtain data that were missing or insufficient in their report that we needed to assess eligibility of the studies or as input for meta‐analysis, or both. If statistics were missing, such as SD, we calculated them from other available statistics (e.g. 95% CIs), according to the methods described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD013273-bbs2-0044" title="HigginsJP , AltmanDG , SterneJA . Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). </p> </section> <section id="CD013273-sec-0054"> <h4 class="title">Assessment of heterogeneity</h4> <p>We examined heterogeneity using visual inspection of effect size distribution and overlap of the CIs in forest plots, as well as using results of the Chi² test and the I² statistic as recommended in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD013273-bbs2-0044" title="HigginsJP , AltmanDG , SterneJA . Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). We considered studies to be statistically heterogeneous if the I² statistic was greater than 50%. </p> </section> <section id="CD013273-sec-0055"> <h4 class="title">Assessment of reporting biases</h4> <p>We planned to use funnel plots to assess publication bias but we had fewer than 10 trials included in any particular pooled analysis. </p> </section> <section id="CD013273-sec-0056"> <h4 class="title">Data synthesis</h4> <p>We entered all quantitative results into Review Manager 5 (<a href="./references#CD013273-bbs2-0057" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">Review Manager 2012</a>). We pooled data (statistical pooling with meta‐analysis) for the comparison paracetamol versus placebo for each outcome for which data were reported in trials. We used a random‐effects model for all analyses. </p> <section id="CD013273-sec-0057"> <h5 class="title">'Summary of findings' table</h5> <p>We created <a href="./full#CD013273-tbl-0001">summary of findings Table for the main comparison</a> for the following outcomes: pain, physical function, quality of life, any adverse events, serious adverse events, withdrawals due to adverse events, and liver toxicity (positive for abnormal results on liver function tests). We included data from the short‐term follow‐up times (three to 12 weeks) for pain and function and data from the last follow‐up time point (between 12 and 24 weeks) for adverse events and withdrawals. </p> <p>We used the GRADE system to assess the quality of the evidence for each pooled analysis (<a href="./references#CD013273-bbs2-0041" title="GuyattGH , CookDJ , JaeschkeR , PaukerSG , SchünemannHJ . Grades of recommendation for antithrombotic agents: American College of Chest Physicians Evidence‐Based Clinical Practice Guidelines (8th Edition). Chest2008;133(6):123S‐31S. ">Guyatt 2008</a>), defined as the extent of confidence into the estimates of treatment benefits and harms, with outcomes of interest being ranked according to their relevance for clinical decision making as of limited importance, important, or critical (<a href="./references#CD013273-bbs2-0042" title="GuyattG , OxmanAD , AklEA , KunzR , VistG , BrozekJ , et al. GRADE guidelines: 1. Introduction – GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology2011;64(4):383‐94. ">Guyatt 2011</a>). The overall quality of the evidence for each outcome was based on 'Risk of bias,' publication bias, inconsistency of results, indirectness, and imprecision (<a href="./references#CD013273-bbs2-0041" title="GuyattGH , CookDJ , JaeschkeR , PaukerSG , SchünemannHJ . Grades of recommendation for antithrombotic agents: American College of Chest Physicians Evidence‐Based Clinical Practice Guidelines (8th Edition). Chest2008;133(6):123S‐31S. ">Guyatt 2008</a>; <a href="./references#CD013273-bbs2-0044" title="HigginsJP , AltmanDG , SterneJA . Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). For 'Risk of bias,' we downgraded the quality of the evidence if more than 25% of participants were from studies with an overall high 'Risk of bias.' We aimed to assess publication bias by visual inspection of funnel plots (scatterplot of the effect of estimates from individual studies against its standard error) and also by the results of Egger's test (small‐study effects) (<a href="./references#CD013273-bbs2-0035" title="EggerM , Zellweger‐ZähnerT , SchneiderM , JunkerC , LengelerC , AntesG . Language bias in randomised controlled trials published in English and German. Lancet1997;2(305):326‐9. ">Egger 1997</a>). If the Egger's test result was significant (two tailed P &lt; 0.1), we downgraded the quality of evidence (GRADE) by one level for publication bias for all meta‐analyses (<a href="./references#CD013273-bbs2-0042" title="GuyattG , OxmanAD , AklEA , KunzR , VistG , BrozekJ , et al. GRADE guidelines: 1. Introduction – GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology2011;64(4):383‐94. ">Guyatt 2011</a>). Results were downgraded for inconsistency if there was significant heterogeneity present by visual inspection or if the I² value was greater than 50%. We downgraded the evidence for imprecision if the limits of the 95% CI crossed the MCID for continuous outcomes, or there were fewer than 200 events for dichotomous outcomes. The GRADE Working Group recommends four levels of evidence: </p> <p> <ul id="CD013273-list-0009"> <li> <p>high‐quality evidence: further research is very unlikely to change confidence in estimate of effect; </p> </li> <li> <p>moderate‐quality evidence: further research is likely to have an important impact on confidence in estimate of effect and may change the estimate; </p> </li> <li> <p>low‐quality evidence: further research is very likely to have an important impact on confidence in estimate of effect and is likely to change the estimate; </p> </li> <li> <p>very low‐quality evidence: very little confidence in the effect estimate.</p> </li> </ul> </p> </section> </section> <section id="CD013273-sec-0058"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned subgroup analyses to assess if pain and function differed between people with hip or knee osteoarthritis, and with the dose of paracetamol (3.0 g/day or less versus 3.9 g/day or more). </p> </section> <section id="CD013273-sec-0059"> <h4 class="title">Sensitivity analysis</h4> <p>We conducted no sensitivity analyses for this review.</p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD013273-sec-0060" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD013273-sec-0060"></div> <section id="CD013273-sec-0061"> <h3 class="title">Description of studies</h3> <p>See: <a href="./references#CD013273-sec-0116" title="">Characteristics of included studies</a>; <a href="./references#CD013273-sec-0117" title="">Characteristics of excluded studies</a>; and <a href="./references#CD013273-sec-0118" title="">Characteristics of ongoing studies</a> tables. </p> <section id="CD013273-sec-0062"> <h4 class="title">Results of the search</h4> <p>The updated search resulted in 1033 additional records with duplicates: 127 additional references from CENTRAL, 242 from MEDLINE, 243 from Embase, 15 from AMED, 250 from CINAHL, 113 from Web of Sciences, 17 from LILACS, and 26 from IPA. After excluding 307 duplicates, we screened 726 titles and abstracts, and eight additional potentially relevant papers for full‐text evaluation. There were no new studies for inclusion in this update, therefore, we analysed the original nine records, or 10 randomised controlled trials (<a href="./references#CD013273-bbs2-0001" title="AltmanRD , ZinsenheimJR , TempleAR , SchweinleJE . Three‐month efficacy and safety of acetaminophen extended‐release for osteoarthritis pain of the hip or knee: a randomized, double‐blind, placebo‐controlled study. Osteoarthritis and Cartilage2007;15:454‐61. ">Altman 2007</a>; <a href="./references#CD013273-bbs2-0002" title="AmadioP , DoyleM . Evaluation of acetaminophen in the management of osteoarthritis of the knee. Current Therapeutic Research – Clinical and Experimental1983;34(1):59‐66. ">Amadio 1983</a>; <a href="./references#CD013273-bbs2-0003" title="CaseJP , BaliunasAJ , BlockJA . Lack of efficacy of acetaminophen in treating symptomatic knee osteoarthritis: a randomized, double‐blind, placebo‐controlled comparison trial with diclofenac sodium. Archives of Internal Medicine2003;163(2):169‐78. ">Case 2003</a>; <a href="./references#CD013273-bbs2-0004" title="GoldenHE , MoskowitzRW , MinicM . Analgesic efficacy and safety of nonprescription doses of naproxen sodium compared with acetaminophen in the treatment of osteoarthritis of the knee. American Journal of Therapeutics2004;11:85‐94. ">Golden 2004</a>; <a href="./references#CD013273-bbs2-0005" title="Herrero‐BeaumontG , IvorraJA , DelCarmen TrabadoM , BlancoFJ , BenitoP , Martín‐MolaE , et al. Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double‐blind, placebo‐controlled study using acetaminophen as a side comparator. Arthritis and Rheumatism2007;56(2):555‐67. ">Herrero‐Beaumont 2007</a>; <a href="./references#CD013273-bbs2-0006" title="Miceli‐RichardC , LeBarsM , SchmidelyN , DougadosM . Paracetamol in osteoarthritis of the knee. Annals of the Rheumatic Diseases2004;63(8):923‐30. ">Miceli‐Richard 2004</a>; <a href="./references#CD013273-bbs2-0007" title="PincusT , KochG , LeiH , MangalB , MangalB , SokkaT , MoskowitzR , et al. Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis. Annals of the Rheumatic Diseases2004;63(8):931‐9. ">Pincus 2004a</a>; <a href="./references#CD013273-bbs2-0008" title="PincusT , KochG , LeiH , MangalB , MangalB , SokkaT , MoskowitzR , et al. Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis. Annals of the Rheumatic Diseases2004;63(8):931‐9. ">Pincus 2004b</a>; <a href="./references#CD013273-bbs2-0009" title="PriorMJ , HarrisonDD , FrustaciME . A randomized, double‐blind, placebo‐controlled 12 week trial of acetaminophen extended release for the treatment of signs and symptoms of osteoarthritis. Current Medical Research &amp; Opinion2014;30(11):2377‐87. ">Prior 2014</a>; <a href="./references#CD013273-bbs2-0010" title="ZoppiM , PerettiG , BoccardE . Placebo‐controlled study of the analgesic efficacy of an effervescent formulation of 500 mg paracetamol in arthritis of the knee or the hip. European Journal of Pain1995;16:1‐2. ">Zoppi 1995</a>). We presented the flow chart of the original and updated search in <a href="#CD013273-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD013273-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Prisma flow diagram of trials investigating efficacy of paracetamol versus placebo for osteoarthritis." data-id="CD013273-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Prisma flow diagram of trials investigating efficacy of paracetamol versus placebo for osteoarthritis. </p> </div> </div> </div> </section> <section id="CD013273-sec-0063"> <h4 class="title">Included studies</h4> <p>The review includes nine records reporting 10 randomised controlled trials and yielded a pooled sample size of 3541 participants. One paper reported on the results of two separate randomised trials (<a href="./references#CD013273-bbs2-0007" title="PincusT , KochG , LeiH , MangalB , MangalB , SokkaT , MoskowitzR , et al. Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis. Annals of the Rheumatic Diseases2004;63(8):931‐9. ">Pincus 2004a</a>; <a href="./references#CD013273-bbs2-0008" title="PincusT , KochG , LeiH , MangalB , MangalB , SokkaT , MoskowitzR , et al. Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis. Annals of the Rheumatic Diseases2004;63(8):931‐9. ">Pincus 2004b</a>). Details of included studies are listed in the <a href="./references#CD013273-sec-0116" title="">Characteristics of included studies</a> table. Years of publication ranged from 1983 to 2014 and all studies were double‐blind randomised placebo‐controlled trials. The follow‐up time ranged from one to 24 weeks. Paracetamol was administered orally (as tablets or capsules). The total oral dose and dose regimens for paracetamol varied across trials. Doses ranged from 1.95 g/day to 4 g/day, but no trials used paracetamol doses between 3.0 to 3.9 g/day. One trial used a three‐arm design (<a href="./references#CD013273-bbs2-0001" title="AltmanRD , ZinsenheimJR , TempleAR , SchweinleJE . Three‐month efficacy and safety of acetaminophen extended‐release for osteoarthritis pain of the hip or knee: a randomized, double‐blind, placebo‐controlled study. Osteoarthritis and Cartilage2007;15:454‐61. ">Altman 2007</a>), and all three treatment groups were included in the meta‐analyses following the recommendation in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD013273-bbs2-0044" title="HigginsJP , AltmanDG , SterneJA . Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). The washout period before treatment started varied across trials, ranging from one day to six months. The washout periods were 12 weeks for corticosteroids, six weeks for intra‐articular steroids, and three days to two weeks for NSAIDs. Participants stopped taking simple analgesics from one to 10 days. One trial reported that the washout for glucosamine drugs was six months, and two trials used "five half lives" to define this period. Nine trials used the diagnosis of osteoarthritis based on image evidence and clinical assessment, whereas one trial based the diagnosis solely on image evidence. </p> </section> <section id="CD013273-sec-0064"> <h4 class="title">Excluded studies</h4> <p>For this update, after retrieving the full text for final assessment, the review authors excluded eight studies: three were not randomised controlled trials (<a href="./references#CD013273-bbs2-0013" title="PapouA , HussainS , McWilliamsD , ZhangW , DohertyM . Sensitivity to change of SF‐36 health survey and patient generated index in people with chronic knee pain commenced on oral analgesia: analysis of data from a clinical trial. Annals of the Rheumatic Diseases2015;74:363. ">Papou 2015</a>; <a href="./references#CD013273-bbs2-0016" title="vanTunenJA , van derLeedenM , BosWH , CheungJ , van derEschM , GerritsenM , et al. Optimization of analgesics for greater exercise therapy participation among patients with knee osteoarthritis and severe pain: a feasibility study. Arthritis Care and Research2016;68(3):332‐40. ">van Tunen 2016</a>; <a href="./references#CD013273-bbs2-0018" title="ZhengY , KostenbaderK , BarrettT , HisawE , GiulianiMJ , ChenY , YoungJL . Tolerability of biphasic‐release hydrocodone bitartrate/acetaminophen tablets (MNK‐155): a phase III, multicenter, open‐label study in patients with osteoarthritis or chronic low back pain. Clinical Therapeutics2015;1(37):1235‐47. ">Zheng 2015</a>), one study did not investigate paracetamol and lacked a placebo control group (<a href="./references#CD013273-bbs2-0015" title="SkouST , RasmussenS , LaursenMB , RathleffMS , Arendt‐NielsenL , SimonsenO , et al. The efficacy of 12 weeks non‐surgical treatment for patients not eligible for total knee replacement: a randomized controlled trial with 1‐year follow‐up. Osteoarthritis and Cartilage2015;23(9):1465‐75. ">Skou 2015</a>), one study did not include people with hip or knee osteoarthritis (<a href="./references#CD013273-bbs2-0014" title="ParkYB , HaCW , ChoSD , LeeMC , LeeJH , SeoSS , et al. A randomized study to compare the efficacy and safety of extended‐release and immediate‐release tramadol HCl/acetaminophen in patients with acute pain following total knee replacement. Current Medical Research and Opinion2015;31(1):75‐84. ">Park 2015</a>), two trials did not investigate paracetamol (<a href="./references#CD013273-bbs2-0011" title="HaCW , ParkYB , MinBW , HanSB , LeeJH , WonYY , et al. Prospective, randomized, double‐blinded, double‐dummy and multicenter phase IV clinical study comparing the efficacy and safety of PG201 (Layla) and SKI306X in patients with osteoarthritis. Journal of Ethnopharmacology2016;181:1‐7. ">Ha 2016</a>; <a href="./references#CD013273-bbs2-0012" title="LaoL , HochbergM , LeeDY , GilpinAM , FongHH , LangenbergP , et al. Huo‐Luo‐Xiao‐Ling (HLXL)‐Dan, a Traditional Chinese Medicine, for patients with osteoarthritis of the knee: a multi‐site, randomized, double‐blind, placebo‐controlled phase II clinical trial. Osteoarthritis and Cartilage2015;23(12):2102‐8. ">Lao 2015</a>), and one trial lacked a placebo control group (<a href="./references#CD013273-bbs2-0017" title="VerkleijSP , LuijsterburgPA , WillemsenSP , KoesBW , BohnenAM , Bierma‐ZeinstraSM . Effectiveness of diclofenac versus paracetamol in knee osteoarthritis: a randomised controlled trial in primary care. British Journal of General Practice2015;65(637):530‐7. ">Verkleij 2015</a>). See <a href="./references#CD013273-sec-0117" title="">Characteristics of excluded studies</a> table. </p> <section id="CD013273-sec-0065"> <h5 class="title">Ongoing studies</h5> <p>An additional search for protocols or unpublished trials identified 74 records. Five ongoing studies that fit the inclusion criteria were found on ClinicalTrials.gov and WHO ICTRP. One registered clinical trial was withdrawn (<a href="./references#CD013273-bbs2-0021" title="Maxi‐Analgesic OA Study: multicentre, double‐blind, placebo‐controlled, randomized, parallel group comparison of the effects of Maxigesic 325 with acetaminophen or ibuprofen on patients with pain from osteoarthritis. Ongoing study 22 August 2011. ">NCT01420666</a>), and two had no results posted online (<a href="./references#CD013273-bbs2-0019" title="A randomized, blinded, comparator‐controlled trial investigating a 28‐day course of Lyrica in participants with knee osteoarthritis who exhibit neuropathic pain, compared with a 28‐day course of acetaminophen. Ongoing study 17 June 2013. ">ACTRN12613000840785</a>; <a href="./references#CD013273-bbs2-0023" title="Proof‐of‐concept study to assess the efficacy, tolerability and safety of a single intraarticular dose of GZ389988 versus placebo in patients with painful osteoarthritis of the knee. Ongoing study 27 July 2016. ">NCT02845271</a>). Two records provided results posted online, but not in a peer‐reviewed journal (<a href="./references#CD013273-bbs2-0020" title="A randomised, double‐blind, evaluation of the effects of paracetamol on the BOLD fMRI response to painful stimuli in subjects with osteoarthritis. Ongoing study 1 September 2010. ">NCT01105936</a>; <a href="./references#CD013273-bbs2-0022" title="An efficacy and safety study of sustained‐release paracetamol in subjects with osteoarthritis. Ongoing study 9 December 2014. ">NCT02311881</a>). </p> </section> </section> </section> <section id="CD013273-sec-0066"> <h3 class="title">Risk of bias in included studies</h3> <p>The results from the 'Risk of bias' assessment are summarised in <a href="#CD013273-fig-0002">Figure 2</a> and <a href="#CD013273-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD013273-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD013273-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD013273-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD013273-fig-0003" src="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD013273-sec-0067"> <h4 class="title">Allocation</h4> <p>In general, included trials did not describe their randomisation and allocation processes adequately and were at unclear risk of selection bias. Only two trials adopted appropriate methods of sequence generation and allocation concealment and were at low risk of selection bias (<a href="./references#CD013273-bbs2-0005" title="Herrero‐BeaumontG , IvorraJA , DelCarmen TrabadoM , BlancoFJ , BenitoP , Martín‐MolaE , et al. Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double‐blind, placebo‐controlled study using acetaminophen as a side comparator. Arthritis and Rheumatism2007;56(2):555‐67. ">Herrero‐Beaumont 2007</a>; <a href="./references#CD013273-bbs2-0009" title="PriorMJ , HarrisonDD , FrustaciME . A randomized, double‐blind, placebo‐controlled 12 week trial of acetaminophen extended release for the treatment of signs and symptoms of osteoarthritis. Current Medical Research &amp; Opinion2014;30(11):2377‐87. ">Prior 2014</a>). </p> </section> <section id="CD013273-sec-0068"> <h4 class="title">Blinding</h4> <p>All included trials successfully reported blinding of participants, personnel, and outcome assessors and were at low risk of performance and detection bias. </p> </section> <section id="CD013273-sec-0069"> <h4 class="title">Incomplete outcome data</h4> <p>Four studies had follow‐up rates of 90% or higher were at low risk of attrition bias (<a href="./references#CD013273-bbs2-0003" title="CaseJP , BaliunasAJ , BlockJA . Lack of efficacy of acetaminophen in treating symptomatic knee osteoarthritis: a randomized, double‐blind, placebo‐controlled comparison trial with diclofenac sodium. Archives of Internal Medicine2003;163(2):169‐78. ">Case 2003</a>; <a href="./references#CD013273-bbs2-0004" title="GoldenHE , MoskowitzRW , MinicM . Analgesic efficacy and safety of nonprescription doses of naproxen sodium compared with acetaminophen in the treatment of osteoarthritis of the knee. American Journal of Therapeutics2004;11:85‐94. ">Golden 2004</a>; <a href="./references#CD013273-bbs2-0006" title="Miceli‐RichardC , LeBarsM , SchmidelyN , DougadosM . Paracetamol in osteoarthritis of the knee. Annals of the Rheumatic Diseases2004;63(8):923‐30. ">Miceli‐Richard 2004</a>; <a href="./references#CD013273-bbs2-0010" title="ZoppiM , PerettiG , BoccardE . Placebo‐controlled study of the analgesic efficacy of an effervescent formulation of 500 mg paracetamol in arthritis of the knee or the hip. European Journal of Pain1995;16:1‐2. ">Zoppi 1995</a>). Two trials were at high risk of attrition bias due to high dropout rates (<a href="./references#CD013273-bbs2-0001" title="AltmanRD , ZinsenheimJR , TempleAR , SchweinleJE . Three‐month efficacy and safety of acetaminophen extended‐release for osteoarthritis pain of the hip or knee: a randomized, double‐blind, placebo‐controlled study. Osteoarthritis and Cartilage2007;15:454‐61. ">Altman 2007</a>; <a href="./references#CD013273-bbs2-0002" title="AmadioP , DoyleM . Evaluation of acetaminophen in the management of osteoarthritis of the knee. Current Therapeutic Research – Clinical and Experimental1983;34(1):59‐66. ">Amadio 1983</a>), and the remaining four trials were at unclear risk, since there were no significant differences in the reasons for dropout between the groups despite the large dropout rate. </p> </section> <section id="CD013273-sec-0070"> <h4 class="title">Selective reporting</h4> <p>One trial did not include measures of physical function (<a href="./references#CD013273-bbs2-0010" title="ZoppiM , PerettiG , BoccardE . Placebo‐controlled study of the analgesic efficacy of an effervescent formulation of 500 mg paracetamol in arthritis of the knee or the hip. European Journal of Pain1995;16:1‐2. ">Zoppi 1995</a>), and one trial did not report pain outcome measures (<a href="./references#CD013273-bbs2-0002" title="AmadioP , DoyleM . Evaluation of acetaminophen in the management of osteoarthritis of the knee. Current Therapeutic Research – Clinical and Experimental1983;34(1):59‐66. ">Amadio 1983</a>), and were at unclear risk of reporting bias. </p> </section> <section id="CD013273-sec-0071"> <h4 class="title">Other potential sources of bias</h4> <p>Six trials were funded by companies that produced paracetamol and were at unclear risk of bias for the other sources of bias domain (<a href="./references#CD013273-bbs2-0001" title="AltmanRD , ZinsenheimJR , TempleAR , SchweinleJE . Three‐month efficacy and safety of acetaminophen extended‐release for osteoarthritis pain of the hip or knee: a randomized, double‐blind, placebo‐controlled study. Osteoarthritis and Cartilage2007;15:454‐61. ">Altman 2007</a>; <a href="./references#CD013273-bbs2-0004" title="GoldenHE , MoskowitzRW , MinicM . Analgesic efficacy and safety of nonprescription doses of naproxen sodium compared with acetaminophen in the treatment of osteoarthritis of the knee. American Journal of Therapeutics2004;11:85‐94. ">Golden 2004</a>; <a href="./references#CD013273-bbs2-0005" title="Herrero‐BeaumontG , IvorraJA , DelCarmen TrabadoM , BlancoFJ , BenitoP , Martín‐MolaE , et al. Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double‐blind, placebo‐controlled study using acetaminophen as a side comparator. Arthritis and Rheumatism2007;56(2):555‐67. ">Herrero‐Beaumont 2007</a>; <a href="./references#CD013273-bbs2-0007" title="PincusT , KochG , LeiH , MangalB , MangalB , SokkaT , MoskowitzR , et al. Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis. Annals of the Rheumatic Diseases2004;63(8):931‐9. ">Pincus 2004a</a>; <a href="./references#CD013273-bbs2-0008" title="PincusT , KochG , LeiH , MangalB , MangalB , SokkaT , MoskowitzR , et al. Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis. Annals of the Rheumatic Diseases2004;63(8):931‐9. ">Pincus 2004b</a>; <a href="./references#CD013273-bbs2-0009" title="PriorMJ , HarrisonDD , FrustaciME . A randomized, double‐blind, placebo‐controlled 12 week trial of acetaminophen extended release for the treatment of signs and symptoms of osteoarthritis. Current Medical Research &amp; Opinion2014;30(11):2377‐87. ">Prior 2014</a>). </p> </section> </section> <section id="CD013273-sec-0072"> <h3 class="title" id="CD013273-sec-0072">Effects of interventions</h3> <p>See: <a href="./full#CD013273-tbl-0001"><b>Summary of findings for the main comparison</b> Paracetamol versus placebo for hip or knee osteoarthritis</a> </p> <p>Results are presented separately according to outcome measures and follow‐up time points. No studies measured results after six months, thus we reported pain and physical function outcomes at immediate term (two weeks or less) and short term (more than two weeks to three months or less) only. </p> <section id="CD013273-sec-0073"> <h4 class="title">Major outcomes</h4> <section id="CD013273-sec-0074"> <h5 class="title">Pain intensity</h5> <p>There was high‐quality evidence that paracetamol provided a small, likely clinically unimportant improvement in pain in the immediate term (MD –3.32, 95% CI –5.83 to –0.81; <a href="./references#CD013273-fig-0007" title="">Analysis 1.1</a>; <a href="#CD013273-fig-0004">Figure 4</a>) and the short term (MD –3.23, 95% CI –5.43 to –1.02; <a href="./references#CD013273-fig-0007" title="">Analysis 1.1</a>; <a href="#CD013273-fig-0004">Figure 4</a>; <a href="./full#CD013273-tbl-0001">summary of findings Table for the main comparison</a>). </p> <div class="figure" id="CD013273-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Hip or knee osteoarthritis, outcome: 1.1 Pain. Pain scores are expressed on scale of 0 to 100. Immediate term = follow‐up two weeks or less; short term = follow‐up more than two weeks but three months or less." data-id="CD013273-fig-0004" src="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Hip or knee osteoarthritis, outcome: 1.1 Pain. Pain scores are expressed on scale of 0 to 100. Immediate term = follow‐up two weeks or less; short term = follow‐up more than two weeks but three months or less. </p> </div> </div> </div> </section> <section id="CD013273-sec-0075"> <h5 class="title">Physical function</h5> <p>Moderate‐quality evidence (downgraded for inconsistency) indicating there was probably no difference between groups in physical function in the immediate term (MD –1.83, 95% CI –6.41 to 2.75; <a href="./references#CD013273-fig-0008" title="">Analysis 1.2</a>; <a href="#CD013273-fig-0005">Figure 5</a>), and high‐quality evidence indicated a small clinically unimportant improvement with paracetamol in the short term (MD –2.92, 95% CI –4.89 to –0.95; <a href="./references#CD013273-fig-0008" title="">Analysis 1.2</a>; <a href="#CD013273-fig-0005">Figure 5</a>; <a href="./full#CD013273-tbl-0001">summary of findings Table for the main comparison</a>). </p> <div class="figure" id="CD013273-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Hip or knee osteoarthritis, outcome: 1.2 Physical function (WOMAC). Physical function scores expressed on scale of 0 to 100. Immediate term = follow‐up two weeks or less; short term = follow‐up two weeks or greater but three months or less." data-id="CD013273-fig-0005" src="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Hip or knee osteoarthritis, outcome: 1.2 Physical function (WOMAC). Physical function scores expressed on scale of 0 to 100. Immediate term = follow‐up two weeks or less; short term = follow‐up two weeks or greater but three months or less. </p> </div> </div> </div> </section> <section id="CD013273-sec-0076"> <h5 class="title">Quality of life</h5> <p>None of the studies measured quality of life.</p> </section> <section id="CD013273-sec-0077"> <h5 class="title">Withdrawals due to adverse events</h5> <p>There was less certainty due to small event rates, indicating imprecision (moderate‐quality evidence), around the risk of withdrawals due to adverse events with paracetamol (RR 1.19, 95% CI 0.91 to 1.55). </p> </section> <section id="CD013273-sec-0078"> <h5 class="title">Total adverse events</h5> <p>There was high‐quality evidence indicating that the risk of any adverse event was similar between paracetamol and placebo treatment groups (RR 1.01, 95% CI 0.92 to 1.11; <a href="./references#CD013273-fig-0009" title="">Analysis 1.3</a>; <a href="#CD013273-fig-0006">Figure 6</a>; <a href="./full#CD013273-tbl-0001">summary of findings Table for the main comparison</a>). </p> <div class="figure" id="CD013273-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Hip or knee osteoarthritis, outcome: 1.4 Adverse events (AE). Any = number of participants reporting any AE; serious = number of participants reporting any serious AE (as defined by each study); withdrawals = number of participants withdrawn from study because of AEs; liver = number of participants with abnormal results on liver function tests." data-id="CD013273-fig-0006" src="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Hip or knee osteoarthritis, outcome: 1.4 Adverse events (AE). Any = number of participants reporting any AE; serious = number of participants reporting any serious AE (as defined by each study); withdrawals = number of participants withdrawn from study because of AEs; liver = number of participants with abnormal results on liver function tests. </p> </div> </div> </div> </section> <section id="CD013273-sec-0079"> <h5 class="title">Liver toxicity</h5> <p>Abnormal liver function tests were more likely to occur with paracetamol (RR 3.79, 95% CI 1.94 to 7.39), but the evidence was downgraded due to wide CIs (imprecision), indicating uncertainty around these effect estimates. </p> </section> <section id="CD013273-sec-0080"> <h5 class="title">Serious adverse events</h5> <p>There was less certainty due to small event rates, indicating imprecision (moderate‐quality evidence), around the risk of serious adverse events with paracetamol (RR 1.36, 95% CI 0.73 to 2.53). </p> </section> </section> <section id="CD013273-sec-0081"> <h4 class="title">Minor outcomes</h4> <p>Low‐quality evidence for minor outcomes was available from single studies only with potential risk of selection or attrition bias (downgraded for risk of bias and imprecision). </p> <section id="CD013273-sec-0082"> <h5 class="title">Walking disability</h5> <p>It was uncertain if walking disability (measured using the 50‐foot walking test) differed between paracetamol and placebo groups in the immediate term (RR –0.55, 95% CI –2.09 to 0.99) and short term (RR 0.06, 95% CI –2.44 to 2.56; <a href="./references#CD013273-fig-0010" title="">Analysis 1.4</a>). </p> </section> <section id="CD013273-sec-0083"> <h5 class="title">Rescue medication</h5> <p>it was uncertain if the use of rescue analgesic medication differed between paracetamol and placebo groups (RR 0.86, 95% CI 0.77 to 0.97; <a href="./references#CD013273-fig-0011" title="">Analysis 1.5</a>). </p> </section> <section id="CD013273-sec-0084"> <h5 class="title">Patient adherence</h5> <p>it is uncertain if adherence to treatment differed between paracetamol and placebo groups adherence to treatment (RR 0.95, 95% CI 0.87 to 1.03; <a href="./references#CD013273-fig-0012" title="">Analysis 1.6</a>). </p> </section> <section id="CD013273-sec-0085"> <h5 class="title">Long‐term toxicity</h5> <p>None of the studies measured long‐term toxicity.</p> </section> </section> <section id="CD013273-sec-0086"> <h4 class="title">Subgroup analyses</h4> <p>We planned subgroup analyses to assess for potential differences in outcomes in participants with knee osteoarthritis and those with hip osteoarthritis, but data for participants with hip and knee osteoarthritis were not presented separately in the included studies. A subset of trials included participants with knee osteoarthritis only (<a href="./references#CD013273-bbs2-0002" title="AmadioP , DoyleM . Evaluation of acetaminophen in the management of osteoarthritis of the knee. Current Therapeutic Research – Clinical and Experimental1983;34(1):59‐66. ">Amadio 1983</a>; <a href="./references#CD013273-bbs2-0003" title="CaseJP , BaliunasAJ , BlockJA . Lack of efficacy of acetaminophen in treating symptomatic knee osteoarthritis: a randomized, double‐blind, placebo‐controlled comparison trial with diclofenac sodium. Archives of Internal Medicine2003;163(2):169‐78. ">Case 2003</a>; <a href="./references#CD013273-bbs2-0004" title="GoldenHE , MoskowitzRW , MinicM . Analgesic efficacy and safety of nonprescription doses of naproxen sodium compared with acetaminophen in the treatment of osteoarthritis of the knee. American Journal of Therapeutics2004;11:85‐94. ">Golden 2004</a>; <a href="./references#CD013273-bbs2-0005" title="Herrero‐BeaumontG , IvorraJA , DelCarmen TrabadoM , BlancoFJ , BenitoP , Martín‐MolaE , et al. Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double‐blind, placebo‐controlled study using acetaminophen as a side comparator. Arthritis and Rheumatism2007;56(2):555‐67. ">Herrero‐Beaumont 2007</a>; <a href="./references#CD013273-bbs2-0006" title="Miceli‐RichardC , LeBarsM , SchmidelyN , DougadosM . Paracetamol in osteoarthritis of the knee. Annals of the Rheumatic Diseases2004;63(8):923‐30. ">Miceli‐Richard 2004</a>), and four trials reported pain and function (<a href="./references#CD013273-bbs2-0003" title="CaseJP , BaliunasAJ , BlockJA . Lack of efficacy of acetaminophen in treating symptomatic knee osteoarthritis: a randomized, double‐blind, placebo‐controlled comparison trial with diclofenac sodium. Archives of Internal Medicine2003;163(2):169‐78. ">Case 2003</a>; <a href="./references#CD013273-bbs2-0004" title="GoldenHE , MoskowitzRW , MinicM . Analgesic efficacy and safety of nonprescription doses of naproxen sodium compared with acetaminophen in the treatment of osteoarthritis of the knee. American Journal of Therapeutics2004;11:85‐94. ">Golden 2004</a>; <a href="./references#CD013273-bbs2-0005" title="Herrero‐BeaumontG , IvorraJA , DelCarmen TrabadoM , BlancoFJ , BenitoP , Martín‐MolaE , et al. Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double‐blind, placebo‐controlled study using acetaminophen as a side comparator. Arthritis and Rheumatism2007;56(2):555‐67. ">Herrero‐Beaumont 2007</a>; <a href="./references#CD013273-bbs2-0006" title="Miceli‐RichardC , LeBarsM , SchmidelyN , DougadosM . Paracetamol in osteoarthritis of the knee. Annals of the Rheumatic Diseases2004;63(8):923‐30. ">Miceli‐Richard 2004</a>). Moderate‐quality evidence (downgraded for imprecision) indicated that paracetamol provided no important improvement in pain at immediate follow‐up (MD –1.96, 95% CI –4.19 to 0.27) or short‐term follow‐up (MD –1.37, 95% CI –4.24 to 1.49) (<a href="./references#CD013273-fig-0013" title="">Analysis 2.1</a>). There were similar results for physical function at immediate follow‐up (MD 0.33, 95% CI –3.07 to 3.74) and short‐term follow‐up (MD –1.08, 95% CI –4.66 to 2.50). See: <a href="./references#CD013273-fig-0014" title="">Analysis 2.2</a>; <a href="./references#CD013273-fig-0015" title="">Analysis 2.3</a>. </p> <p>Up to nine trials presented data for the subgroup analysis comparing lower and higher dose of paracetamol (3.0 g/day or less versus 3.9 g/day or more) (<a href="./references#CD013273-bbs2-0001" title="AltmanRD , ZinsenheimJR , TempleAR , SchweinleJE . Three‐month efficacy and safety of acetaminophen extended‐release for osteoarthritis pain of the hip or knee: a randomized, double‐blind, placebo‐controlled study. Osteoarthritis and Cartilage2007;15:454‐61. ">Altman 2007</a>; <a href="./references#CD013273-bbs2-0003" title="CaseJP , BaliunasAJ , BlockJA . Lack of efficacy of acetaminophen in treating symptomatic knee osteoarthritis: a randomized, double‐blind, placebo‐controlled comparison trial with diclofenac sodium. Archives of Internal Medicine2003;163(2):169‐78. ">Case 2003</a>; <a href="./references#CD013273-bbs2-0004" title="GoldenHE , MoskowitzRW , MinicM . Analgesic efficacy and safety of nonprescription doses of naproxen sodium compared with acetaminophen in the treatment of osteoarthritis of the knee. American Journal of Therapeutics2004;11:85‐94. ">Golden 2004</a>; <a href="./references#CD013273-bbs2-0005" title="Herrero‐BeaumontG , IvorraJA , DelCarmen TrabadoM , BlancoFJ , BenitoP , Martín‐MolaE , et al. Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double‐blind, placebo‐controlled study using acetaminophen as a side comparator. Arthritis and Rheumatism2007;56(2):555‐67. ">Herrero‐Beaumont 2007</a>; <a href="./references#CD013273-bbs2-0006" title="Miceli‐RichardC , LeBarsM , SchmidelyN , DougadosM . Paracetamol in osteoarthritis of the knee. Annals of the Rheumatic Diseases2004;63(8):923‐30. ">Miceli‐Richard 2004</a>; <a href="./references#CD013273-bbs2-0007" title="PincusT , KochG , LeiH , MangalB , MangalB , SokkaT , MoskowitzR , et al. Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis. Annals of the Rheumatic Diseases2004;63(8):931‐9. ">Pincus 2004a</a>; <a href="./references#CD013273-bbs2-0008" title="PincusT , KochG , LeiH , MangalB , MangalB , SokkaT , MoskowitzR , et al. Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis. Annals of the Rheumatic Diseases2004;63(8):931‐9. ">Pincus 2004b</a>; <a href="./references#CD013273-bbs2-0009" title="PriorMJ , HarrisonDD , FrustaciME . A randomized, double‐blind, placebo‐controlled 12 week trial of acetaminophen extended release for the treatment of signs and symptoms of osteoarthritis. Current Medical Research &amp; Opinion2014;30(11):2377‐87. ">Prior 2014</a>; <a href="./references#CD013273-bbs2-0010" title="ZoppiM , PerettiG , BoccardE . Placebo‐controlled study of the analgesic efficacy of an effervescent formulation of 500 mg paracetamol in arthritis of the knee or the hip. European Journal of Pain1995;16:1‐2. ">Zoppi 1995</a>). There were no important differences in outcomes for low‐dose versus high‐dose paracetamol with respect to pain in the immediate term (<a href="./references#CD013273-fig-0016" title="">Analysis 3.1</a>) or short term (<a href="./references#CD013273-fig-0017" title="">Analysis 3.2</a>), or physical function in the short term (<a href="./references#CD013273-fig-0019" title="">Analysis 3.4</a>). We could not perform a subgroup analysis in the immediate term for physical function as no studies using lower‐dose paracetamol reported this outcome at this time point. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD013273-sec-0087" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD013273-sec-0087"></div> <section id="CD013273-sec-0088"> <h3 class="title" id="CD013273-sec-0088">Summary of main results</h3> <p>In this update of the systematic review and meta‐analysis by <a href="./references#CD013273-bbs2-0052" title="MachadoGC , MaherCG , FerreiraPH , PinheiroMB , LinCW , DayRO , et al. Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta‐analysis of randomised placebo controlled trials. BMJ2015;350:1225. ">Machado 2015</a>, we included nine eligible records reporting 10 randomised placebo‐controlled trials (3541 participants) on the effects of paracetamol and placebo for people with hip or knee osteoarthritis. Thresholds for clinical importance were chosen a priori and included 9 points for pain and physical function (on a 100‐point scale). In general, there was moderate‐ to high‐quality evidence that treatment effects of paracetamol compared with placebo on both pain and physical function outcomes were, at best, too small to be of clinical relevance for this population. Although the risk of total adverse events likely did not differ between the paracetamol and placebo groups (high‐quality evidence), the use of paracetamol may have increased the risk of abnormal liver test results (moderate‐quality evidence, downgraded for imprecision). However, we acknowledge that the clinical importance of this finding was uncertain. Due to the small number of events, we were less certain if paracetamol use increased the risk of serious adverse events or withdrawals due to adverse events. Our subgroup analyses indicated that the effects on pain and function did not differ according to the dose of paracetamol (3.0 g/day or less versus 3.9 g/day or more). We did not include a responder analysis in this review, as thresholds used to define responders in this field are still not well defined. It is possible, however, that the results of a responder analysis would yield different conclusions. </p> </section> <section id="CD013273-sec-0089"> <h3 class="title" id="CD013273-sec-0089">Overall completeness and applicability of evidence</h3> <p>Paracetamol is the most commonly used non‐prescription medication for musculoskeletal pain, including osteoarthritis (<a href="./references#CD013273-bbs2-0030" title="BrandCA , HarrisonC , TropeaJ , HinmanRS , BrittH , BennellK . Management of osteoarthritis in general practice in Australia. Arthritis Care and Research2014;66:551‐8. ">Brand 2014</a>), but this systematic review has shown that there is moderate‐ to high‐quality evidence that the effects of paracetamol compared with placebo are too small to be of clinically importance for people with hip or knee osteoarthritis. Given only one trial included a follow‐up longer than 12 weeks (<a href="./references#CD013273-bbs2-0005" title="Herrero‐BeaumontG , IvorraJA , DelCarmen TrabadoM , BlancoFJ , BenitoP , Martín‐MolaE , et al. Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double‐blind, placebo‐controlled study using acetaminophen as a side comparator. Arthritis and Rheumatism2007;56(2):555‐67. ">Herrero‐Beaumont 2007</a>), the results of this review are mostly restricted to immediate‐ and short‐term follow‐ups. </p> <p>Previous research has highlighted that the focus on pharmacological interventions for knee and hip osteoarthritis is in disconnect with the best evidence‐based recommendations for care of this condition (<a href="./references#CD013273-bbs2-0029" title="BrandCA . The role of self‐management in designing care for people with osteoarthritis of the hip and knee. Medical Journal of Australia2008;189(S):25‐8. ">Brand 2008</a>; <a href="./references#CD013273-bbs2-0030" title="BrandCA , HarrisonC , TropeaJ , HinmanRS , BrittH , BennellK . Management of osteoarthritis in general practice in Australia. Arthritis Care and Research2014;66:551‐8. ">Brand 2014</a>). For instance, there is a very important component of lifestyle‐based management, such as obesity control and physical activity uptake that is not addressed with pharmacological approaches (<a href="./references#CD013273-bbs2-0028" title="BasedowM , WilliamsH , ShanahanEM , RuncimanWB , EstermanA . Australian GP management of osteoarthritis following the release of the RACGP guideline for the non‐surgical management of hip and knee osteoarthritis. BMC Research Notes2015;5(8):536. ">Basedow 2015</a>; <a href="./references#CD013273-bbs2-0029" title="BrandCA . The role of self‐management in designing care for people with osteoarthritis of the hip and knee. Medical Journal of Australia2008;189(S):25‐8. ">Brand 2008</a>). In fact, evidence has established that physical programmes (e.g. weight loss, exercise including lower limb strengthening exercises) are associated with large effect sizes (greater than 20) on pain reduction in this population (<a href="./references#CD013273-bbs2-0062" title="UthmanO , van derWindtD , JordanJL , DziedzicK , HealeyE , PeatGM , et al. Exercise for lower limb osteoarthritis: systematic review incorporating trial sequential analysis and network meta‐analysis. British Journal of Medicine2013;347:f5555. ">Uthman 2013</a>). Our results showed that pharmacological management of hip or knee osteoarthritis through simple analgesics only offers small and clinically unimportant effects on pain and physical function. </p> </section> <section id="CD013273-sec-0090"> <h3 class="title" id="CD013273-sec-0090">Quality of the evidence</h3> <p>Overall, the quality of evidence for the outcomes measured up to 12 weeks considered critical for clinical decision making (pain, function, and overall adverse events) was high according to the GRADE system. According to the GRADE Working Group, a grading of high quality of evidence indicates that further research is unlikely to change the effect estimates substantially. For serious adverse events (short term), withdrawals due to adverse events and liver toxicity (indicated by abnormal liver function tests), evidence was downgraded from high to moderate due to imprecision (the total number of events was small). According to the GRADE Working Group grades of evidence, a grading of moderate quality of evidence indicates that further research may have an important impact on our confidence in the estimate of effect and is likely to change the estimate. </p> <p>None of the trials measured quality of life or long‐term toxicity outcomes.</p> </section> <section id="CD013273-sec-0091"> <h3 class="title" id="CD013273-sec-0091">Potential biases in the review process</h3> <p>We based our review on an extensive electronic literature search, citation tracking, and search for unpublished trials, so it seems unlikely that we missed relevant trials, provided that they were published as full‐text articles or accessible in conference proceedings or trial registries (<a href="./references#CD013273-bbs2-0036" title="EggerM , JüniP , BartlettC , HolensteinF , SterneJ . How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study. Health Technology Assessment (Winchester, England)2003;7(1):1‐76. ">Egger 2003</a>). Two review authors independently performed selection of trials, data extraction, and 'Risk of bias' assessment to reduce bias and transcription errors (<a href="./references#CD013273-bbs2-0043" title="GøtzschePC , HróbjartssonA , MaricK , TendalB . Data extraction errors in meta‐analyses that use standardized mean differences. JAMA2007;298(4):430‐7. ">Gøtzsche 2007</a>). Therefore, we are confident that potential biases during the review process were minimised. However, the review presented some limitations. The number of studies in each meta‐analysis was relatively small and that prevented us from conducting a small‐study effect analysis using funnel plots. Previous exposure of participants to paracetamol was also frequently reported by included trials, suggesting that a proportion of 'non‐responders' to the medication were possibly included in the analyses. We acknowledge this could have influenced the final results. </p> </section> <section id="CD013273-sec-0092"> <h3 class="title" id="CD013273-sec-0092">Agreements and disagreements with other studies or reviews</h3> <p>The previous non‐Cochrane review on paracetamol for hip or knee osteoarthritis was conducted in 2004 (<a href="./references#CD013273-bbs2-0066" title="ZhangW , JonesA , DohertyM . Does paracetamol (acetaminophen) reduce the pain of osteoarthritis? A meta‐analysis of randomised controlled trials. Annals of the Rheumatic Diseases2004;63(8):901‐7. ">Zhang 2004</a>), after which, six additional randomised placebo‐controlled trials were published. The authors of this previous review included trials of osteoarthritis affecting multiple joints and not just the hip or knee. Moreover, they included analyses comparing NSAIDs versus paracetamol and NSAIDs versus placebo. <a href="./references#CD013273-bbs2-0066" title="ZhangW , JonesA , DohertyM . Does paracetamol (acetaminophen) reduce the pain of osteoarthritis? A meta‐analysis of randomised controlled trials. Annals of the Rheumatic Diseases2004;63(8):901‐7. ">Zhang 2004</a> concluded that paracetamol was an effective analgesic medication for pain relief due to osteoarthritis (standardised mean difference 0.21, 95% CI 0.02 to 0.41). However, in this update of <a href="./references#CD013273-bbs2-0052" title="MachadoGC , MaherCG , FerreiraPH , PinheiroMB , LinCW , DayRO , et al. Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta‐analysis of randomised placebo controlled trials. BMJ2015;350:1225. ">Machado 2015</a>, we included subgroup analyses to verify possible differences between the two body regions (hip and knee) and dose of paracetamol (3 g/day or 4 g/day) on pain and physical function. Our review has provided moderate‐ to high‐quality evidence that the effects of paracetamol on pain and function were not different when comparing hip or knee osteoarthritis or different doses used, and were too small to be considered clinically relevant. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD013273-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/urn:x-wiley:14651858:media:CD013273:CD013273-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_t/tCD013273-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Prisma flow diagram of trials investigating efficacy of paracetamol versus placebo for osteoarthritis." data-id="CD013273-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Prisma flow diagram of trials investigating efficacy of paracetamol versus placebo for osteoarthritis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013273/full#CD013273-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013273-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/urn:x-wiley:14651858:media:CD013273:CD013273-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_t/tCD013273-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD013273-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013273/full#CD013273-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013273-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/urn:x-wiley:14651858:media:CD013273:CD013273-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_t/tCD013273-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD013273-fig-0003" src="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013273/full#CD013273-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013273-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/urn:x-wiley:14651858:media:CD013273:CD013273-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_t/tCD013273-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Hip or knee osteoarthritis, outcome: 1.1 Pain. Pain scores are expressed on scale of 0 to 100. Immediate term = follow‐up two weeks or less; short term = follow‐up more than two weeks but three months or less." data-id="CD013273-fig-0004" src="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Hip or knee osteoarthritis, outcome: 1.1 Pain. Pain scores are expressed on scale of 0 to 100. Immediate term = follow‐up two weeks or less; short term = follow‐up more than two weeks but three months or less. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013273/full#CD013273-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013273-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/urn:x-wiley:14651858:media:CD013273:CD013273-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_t/tCD013273-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Hip or knee osteoarthritis, outcome: 1.2 Physical function (WOMAC). Physical function scores expressed on scale of 0 to 100. Immediate term = follow‐up two weeks or less; short term = follow‐up two weeks or greater but three months or less." data-id="CD013273-fig-0005" src="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Hip or knee osteoarthritis, outcome: 1.2 Physical function (WOMAC). Physical function scores expressed on scale of 0 to 100. Immediate term = follow‐up two weeks or less; short term = follow‐up two weeks or greater but three months or less. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013273/full#CD013273-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013273-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/urn:x-wiley:14651858:media:CD013273:CD013273-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_t/tCD013273-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Hip or knee osteoarthritis, outcome: 1.4 Adverse events (AE). Any = number of participants reporting any AE; serious = number of participants reporting any serious AE (as defined by each study); withdrawals = number of participants withdrawn from study because of AEs; liver = number of participants with abnormal results on liver function tests." data-id="CD013273-fig-0006" src="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Hip or knee osteoarthritis, outcome: 1.4 Adverse events (AE). Any = number of participants reporting any AE; serious = number of participants reporting any serious AE (as defined by each study); withdrawals = number of participants withdrawn from study because of AEs; liver = number of participants with abnormal results on liver function tests. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013273/full#CD013273-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013273-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/urn:x-wiley:14651858:media:CD013273:CD013273-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_t/tCD013273-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Hip or knee osteoarthritis, Outcome 1 Pain intensity." data-id="CD013273-fig-0007" src="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Hip or knee osteoarthritis, Outcome 1 Pain intensity.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013273/references#CD013273-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013273-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/urn:x-wiley:14651858:media:CD013273:CD013273-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_t/tCD013273-CMP-001-02.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Hip or knee osteoarthritis, Outcome 2 Physical function (Western Ontario and McMaster Universities Osteoarthritis Index)." data-id="CD013273-fig-0008" src="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Hip or knee osteoarthritis, Outcome 2 Physical function (Western Ontario and McMaster Universities Osteoarthritis Index). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013273/references#CD013273-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013273-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/urn:x-wiley:14651858:media:CD013273:CD013273-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_t/tCD013273-CMP-001-03.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Hip or knee osteoarthritis, Outcome 3 Adverse events (AE)." data-id="CD013273-fig-0009" src="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Hip or knee osteoarthritis, Outcome 3 Adverse events (AE).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013273/references#CD013273-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013273-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/urn:x-wiley:14651858:media:CD013273:CD013273-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_t/tCD013273-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Hip or knee osteoarthritis, Outcome 4 Walking disability." data-id="CD013273-fig-0010" src="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Hip or knee osteoarthritis, Outcome 4 Walking disability.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013273/references#CD013273-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013273-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/urn:x-wiley:14651858:media:CD013273:CD013273-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_t/tCD013273-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Hip or knee osteoarthritis, Outcome 5 Rescue medication." data-id="CD013273-fig-0011" src="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Hip or knee osteoarthritis, Outcome 5 Rescue medication.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013273/references#CD013273-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013273-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/urn:x-wiley:14651858:media:CD013273:CD013273-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_t/tCD013273-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Hip or knee osteoarthritis, Outcome 6 Patient adherence." data-id="CD013273-fig-0012" src="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Hip or knee osteoarthritis, Outcome 6 Patient adherence.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013273/references#CD013273-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013273-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/urn:x-wiley:14651858:media:CD013273:CD013273-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_t/tCD013273-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Knee osteoarthritis, Outcome 1 Pain intensity." data-id="CD013273-fig-0013" src="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Knee osteoarthritis, Outcome 1 Pain intensity.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013273/references#CD013273-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013273-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/urn:x-wiley:14651858:media:CD013273:CD013273-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_t/tCD013273-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Knee osteoarthritis, Outcome 2 Physical function (Western Ontario and McMaster Universities Osteoarthritis Index)." data-id="CD013273-fig-0014" src="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Knee osteoarthritis, Outcome 2 Physical function (Western Ontario and McMaster Universities Osteoarthritis Index). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013273/references#CD013273-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013273-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/urn:x-wiley:14651858:media:CD013273:CD013273-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_t/tCD013273-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Knee osteoarthritis, Outcome 3 Walking disability." data-id="CD013273-fig-0015" src="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Knee osteoarthritis, Outcome 3 Walking disability.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013273/references#CD013273-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013273-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/urn:x-wiley:14651858:media:CD013273:CD013273-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_t/tCD013273-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Subgroup analysis: paracetamol 3.0 g/day or less versus 3.9 g/day or more, Outcome 1 Pain intensity: immediate term." data-id="CD013273-fig-0016" src="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Subgroup analysis: paracetamol 3.0 g/day or less versus 3.9 g/day or more, Outcome 1 Pain intensity: immediate term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013273/references#CD013273-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013273-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/urn:x-wiley:14651858:media:CD013273:CD013273-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_t/tCD013273-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Subgroup analysis: paracetamol 3.0 g/day or less versus 3.9 g/day or more, Outcome 2 Pain intensity: short term." data-id="CD013273-fig-0017" src="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Subgroup analysis: paracetamol 3.0 g/day or less versus 3.9 g/day or more, Outcome 2 Pain intensity: short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013273/references#CD013273-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013273-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/urn:x-wiley:14651858:media:CD013273:CD013273-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_t/tCD013273-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Subgroup analysis: paracetamol 3.0 g/day or less versus 3.9 g/day or more, Outcome 3 Physical function: immediate term." data-id="CD013273-fig-0018" src="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Subgroup analysis: paracetamol 3.0 g/day or less versus 3.9 g/day or more, Outcome 3 Physical function: immediate term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013273/references#CD013273-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013273-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/urn:x-wiley:14651858:media:CD013273:CD013273-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_t/tCD013273-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Subgroup analysis: paracetamol 3.0 g/day or less versus 3.9 g/day or more, Outcome 4 Physical function: short term." data-id="CD013273-fig-0019" src="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Subgroup analysis: paracetamol 3.0 g/day or less versus 3.9 g/day or more, Outcome 4 Physical function: short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013273/references#CD013273-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013273/media/CDSR/CD013273/image_n/nCD013273-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD013273-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Paracetamol versus placebo for hip or knee osteoarthritis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Paracetamol versus placebo for hip or knee osteoarthritis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Population:</b> people with hip or knee osteoarthritis </p> <p><b>Settings:</b> various rehabilitation, orthopaedic, or rheumatology clinics </p> <p><b>Intervention:</b> paracetamol </p> <p><b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>What happens</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Paracetamol</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean change in pain</b> </p> <p>(0–100 scale)</p> <p>Short term (3–12 weeks), where 0 = no pain</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in pain score in the placebo group was –23<sup>a</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in pain score in the paracetamol group was <b>3.2 points lower</b> (1.0 lower to 5.4 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD –3.23</b> </p> <p>(–5.43 to –1.02)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2355 (7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>High</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinically unimportant improvement; absolute change 3% better (5% better to 1% better); relative change 5% better (2% better to 8% better)<sup>b</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Physical function</b> </p> <p>(WOMAC function 0–100)</p> <p>3–12 weeks, 0 = better function</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in physical function score in the placebo group was –12<sup>a</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean physical function score in the paracetamol group was <b>2.9 points lower</b> (4.9 lower to 1.0 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD –2.92</b> </p> <p>(–4.89 to –0.95)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2354 (7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>High</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinically unimportant improvement; absolute change 3% better (5% better to 1% better); relative change 5% better (2% better to 9% better)<sup>b</sup>. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> <p>Not measured</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Withdrawals due to adverse events</b> </p> <p>24 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>65 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>77 per 1000</b> </p> <p>(59 to 100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.19</b> (0.91 to 1.55) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3023 (7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The difference was not statistically or clinically significant; absolute change 1% more withdrew with paracetamol (1% less to 3% more); relative change 19% more (9% less to 55% more). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total adverse events: number experiencing</b> </p> <p>24 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>325 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>328 per 1000</b><br/> (299 to 360) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.01</b> </p> <p>(0.92 to 1.11)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3252 (8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>High</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The difference was not statistically or clinically significant; absolute change: no more events with paracetamol (3% less to 3% more); relative change 1% more (8% less to 11% more). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Liver toxicity: number experiencing abnormal liver function tests</b> </p> <p>24 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>18 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>70 per 1000</b><br/> (36 to 136) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 3.79</b> </p> <p>(1.94<b>to</b> 7.39) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1237 (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The clinical impact of the higher risk of abnormal liver function tests was unclear; absolute change 5% more abnormal tests with paracetamol (1% more to 10% more); relative change 279% more (94% more to 639% more). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Serious adverse events: number experiencing</b> </p> <p>24 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>11 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>16 per 1000</b><br/> (8 to 29) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.36</b> </p> <p>(0.73 to 2.53)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3209 (6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute change: no more events with paracetamol (up to 1% more); relative change 36% more (27% less to 153% more). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> was the median control group risk across studies. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>MD:</b> mean difference;<b>RR:</b> risk ratio; <b>WOMAC:</b> Western Ontario and McMaster Universities Osteoarthritis Index. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Based on score in placebo group at 3 months' follow‐up as reported in <a href="./references#CD013273-bbs2-0006" title="Miceli‐RichardC , LeBarsM , SchmidelyN , DougadosM . Paracetamol in osteoarthritis of the knee. Annals of the Rheumatic Diseases2004;63(8):923‐30. ">Miceli‐Richard 2004</a>. </p> <p><sup>b</sup>Relative changes calculated as absolute change (mean difference) divided by mean at baseline in the placebo group from <a href="./references#CD013273-bbs2-0006" title="Miceli‐RichardC , LeBarsM , SchmidelyN , DougadosM . Paracetamol in osteoarthritis of the knee. Annals of the Rheumatic Diseases2004;63(8):923‐30. ">Miceli‐Richard 2004</a> (mean values were: 69.0 (standard deviation 17) on 0‐ to 100‐point visual analogue pain scale; and 54.0 (standard deviation 15) on 0‐ to 100‐point WOMAC function subscale). </p> <p><sup>c</sup>Downgraded by one level due to imprecision (small number of events, or the 95% confidence intervals do not exclude a clinically important change). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Paracetamol versus placebo for hip or knee osteoarthritis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013273/full#CD013273-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013273-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Hip or knee osteoarthritis</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Pain intensity <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Immediate term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1686</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.32 [‐5.83, ‐0.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2355</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.23 [‐5.43, ‐1.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Physical function (Western Ontario and McMaster Universities Osteoarthritis Index) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Immediate term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1336</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.83 [‐6.41, 2.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2354</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.92 [‐4.89, ‐0.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Adverse events (AE) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 AE (any)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3252</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.92, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 AE (serious)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3209</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.36 [0.73, 2.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 AE (withdrawals)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3023</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.19 [0.91, 1.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4 AE (liver)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1237</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.79 [1.94, 7.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Walking disability <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Immediate term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>294</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.55 [‐2.09, 0.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [‐2.44, 2.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Rescue medication <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Patient adherence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Hip or knee osteoarthritis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013273/references#CD013273-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013273-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Knee osteoarthritis</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Pain intensity <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Immediate term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1088</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.96 [‐4.19, 0.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>813</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.37 [‐4.24, 1.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Physical function (Western Ontario and McMaster Universities Osteoarthritis Index) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Immediate term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>794</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [‐3.07, 3.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>813</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.08 [‐4.66, 2.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Walking disability <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Immediate term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>294</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.55 [‐2.09, 0.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [‐2.44, 2.56]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Knee osteoarthritis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013273/references#CD013273-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013273-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Subgroup analysis: paracetamol 3.0 g/day or less versus 3.9 g/day or more</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Pain intensity: immediate term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 ≤ 3.0 g/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐9.2 [‐19.59, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 ≥ 3.9 g/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1630</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.98 [‐5.48, ‐0.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Pain intensity: short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 ≤ 3.0 g/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>535</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.88 [‐6.41, 0.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 ≥ 3.9 g/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1985</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.30 [‐6.60, ‐2.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Physical function: immediate term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 ≥ 3.9 g/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1336</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.83 [‐6.41, 2.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Physical function: short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 ≤ 3.0 g/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>535</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.86 [‐6.48, 0.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 ≥ 3.9 g/day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1985</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.07 [‐5.60, ‐0.54]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Subgroup analysis: paracetamol 3.0 g/day or less versus 3.9 g/day or more</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013273/references#CD013273-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD013273&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD013273-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD013273-note-0007">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD013273-note-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD013273-note-0005">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD013273-note-0008">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ms#CD013273-note-0004">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD013273-note-0006">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD013273-note-0003">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD013273-note-0002">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013273\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013273\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013273\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013273"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013273\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013273\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013273\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013273\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013273\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013273"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013273\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013273\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013273\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013273"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013273\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013273\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013273\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013273"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=PMzGcYGP&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013273&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013273';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD013273/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD013273/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013273%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740719288887"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013273/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740719288891"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013273/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918de51ddea89368',t:'MTc0MDcxOTI4OS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 